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ABSTRACT 
 
 Release of home health testing kits into the market has enabled people to take 
care of their own health. Misinterpretation of results and delays in treatments are the 
major concerns of the doctors.  In the present study, two cholesterol test kits, Accuchek® 
Instant plus® and Home Access® Instant Cholesterol Test, were compared on the basis 
of user performance, accuracy, and the patient’s future medical decisions based on the 
test results. The study was conducted with 30 participants, 15 men and 15 women. 
Participants tested their overall cholesterol level with both kits. In addition, a clinical 
cholesterol evaluation, the medical gold standard, was performed. The usability of both 
test kits was evaluated through questionnaires, user task performance, and comparison 
with the clinical evaluation. Participants were questioned on how they would use the 
information once they had seen the result from the first test kit. 
Results of the study found that regardless of the kit used, participants always 
found the first kit used as the more usable kit. Use of both kits resulted in participants 
committing a number of errors. In both cases, errors were primarily attributed to poorly 
written procedural instructions. Since the literature raises the question of test kit 
accuracy, the home health test kit results were compared to the clinical results. 
Inaccuracy of the test kit results did not depend on the type of the test kit used; however, 
the Accuchek® Instant plus® resulted in a greater correlation between the clinical results 
and test kit results regardless of the number of user errors. When participants were asked 
to provide a decision on future health care, predominate number of participants said they 
would change their lifestyle rather than visit a doctor regardless of their cholesterol level. 
A nominal logistic statistical prediction profiler test found that as the cholesterol level 
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increased, participants only changed their decision from that of doing nothing to just 
changing their lifestyle. This finding highlights physicians’ concerns that patients may 
delay treatment for potentially serious conditions even when they have the available 
results. Further studies with larger sample sizes are needed to further evaluate these initial 
findings. 
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1. INTRODUCTION 
A home health test kit is a medical test approved by the United States Food and 
Drug Administration that can be purchased without a prescription and used in the 
privacy of the individual’s home. These tests first appeared in the 1940s for testing 
glucose level in Diabetic patients. At that point, home health testing was primarily 
used for monitoring the status of medical ailments rather than for patient self-
diagnosis and treatment (Gimino & Liang, 1998). Today, the FDA states there are 
approximately 500 approved at home tests and this does not include tests available on 
the Internet that have not been approved  (Sims,2003). The most popular home health 
test is the pregnancy test which was introduced in the 1970s (Valanis & Perlman, 
1982). Presently, test kits are available for testing blood glucose, pregnancy, total 
cholesterol, ovulation, drugs of abuse, colorectal disease, HIV and others.  
Home tests are being used for monitoring medical ailments as well as to 
diagnose health conditions. According to Lynne T. Shuster, M.D, a general internist 
and associate medical editor for Mayo Clinic Women’s health source newsletter, these 
tests help people have a better knowledge about their health condition and take better 
care about themselves (Shelton, 1999). It is also potentially a less expensive 
alternative to visiting the doctor’s clinic. Home health tests are generally used for 
doctor recommended monitoring, detecting health conditions when there are no 
physical signs or noted symptoms or for detecting a health condition when physical 
signs and symptoms exist.  
According to United States Home Diagnostics and Monitoring, a publication of 
Frost and Sullivan’s, a market research, consulting and training company, these home 
diagnostic products and monitoring devices generated $1.89 billion in manufacturer’s 
revenue in 1998. This trend is expected to reach $3.5 billion in five years (Shelton, 
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1999). Many doctors fear that this trend could change the relation between the patients 
and doctor drastically. Misinterpretation of results, delays in treatments and increase in 
demand for medication without the patient being examined first are the major 
concerns of the doctors. The growing popularity of these home health tests is mainly 
due to the increasing cost of professional health care. But in some situations like 
regular monitoring of the blood glucose level in Diabetic patients and monitoring of 
cholesterol level in patients at high heart risk, few doctors are recommending the use 
of these tests. Doctors recommending the tests believe they are cost-effective for the 
patients and time-effective for both the patients and the doctors.  
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2. LITERATURE REVIEW 
2.1 Home Health Tests 
 
 The first home health test kit was introduced in the 1940s (Gimino & Liang, 
1998). At that time home health kits were primarily used for monitoring health 
conditions rather than diagnosis and treatment. Home health tests that measure blood 
glucose, cholesterol level and blood pressure can augment a physician’s treatment by 
providing information about patient’s condition 24 hours a day. Home health tests are 
designed for perform one of the three major purposes: 1) to detect a specific disorder 
or condition (like pregnancy or  ovulation), 2) to detect the presence of a health 
condition whose symptoms are not predisposing ( blood cholesterol level for high 
cholesterol, occult blood in stool for colon or rectal cancer); or 3) to monitor an 
existing health condition so as to change diet or medication according to the severity 
of the situation ( blood pressure for hypertension or blood glucose for diabetes) 
(Gossel, 1988). The most important development that led to the revolutionizing of 
these home health tests is the discovery of monoclonal antibodies and development of 
methods of producing them in almost limitless supply. The monoclonal antibodies 
combine with the specific chemical substance of intent and can then detect a 
substance in extremely small quantities (Gossel, 1988). This has enabled the 
manufacturers to develop inexpensive, easy to use and reproducible tests. All home 
health tests sold to the public are to be approved by the Food and Drug 
Administration. To be approved by the FDA the test must show an accuracy of 95%-
99% and should be easy to use (Gossel, 1988). There are more than 500 approved 
home health tests in the market apart from the tests sold on the internet which have 
not been approved (Sims, 2003). The conditions for approval and exemption have 
been discussed in the section “Human Factors in FDA.” 
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Several terms are used to describe a home health test. Sensitivity refers to how 
well the test can detect the target substance at a level that permits accurate assessment 
of the condition. Specificity is a measure of how accurately the home health test 
measures only the substance that it has to measure (it should not detect any of the 
other substances). Accuracy is the ability of the test to give consistent results. The 
wrong interpretation of the test results are classified into two categories. The false-
positive result occurs when the test results indicate the presence of a condition that 
does not exist. The false-negative result occurs when the test result does not show a 
condition that does exist. If the majority of the test results fall into these two 
categories the reliability of the home health testing kit is questionable (Gossel, 1988).  
 Since the first appearance of these tests in the market, a large number of home 
health tests have been launched in the market. The categories of tests cleared by the 
Food Drug Administration for home use are: 
• Cholesterol – for assessing risk of heart attack 
• Glucose and fructosamine – for monitoring Diabetes 
• hCG – for detecting pregnancy 
• HIV antibody – for determining HIV infection 
• Fecal occult blood – to screen colo-rectal cancer 
• Luteinizing hormone – to predict ovulation 
• Presence of illegal drugs and drugs of abuse 
• Prothrombin time – for monitoring blood thinning and clotting.   
(Glenn, 2001) 
Apart from the above tests, other tests approved by the FDA are the home health tests 
for testing Asthma, Urinary tract infection, Blood pressure, Hepatitis C, Sulphite, 
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Calcium and vision. All home health testing products need FDA approval before they 
can be marketed to the public (Gossel, 1988). 
The popularity of home health test kits as a substitute to a physician can be 
attributed to several factors. Factors that affect the medical care received by people 
can influence the market of these home health kits. The level of utilization of health 
care services gives a clear picture of its accessibility. Ensuring equal accessibility to 
health care services is difficult as the demand for service differs from person to 
person. The known barriers to this utilization are geographic factors, socio-economic 
factors, cost of medical care, education, ethnicity/race and religious beliefs (Field, 
Cart & Briggs, 2001). Other factors like ease of use and confidentiality, which are the 
characteristics of the test kits, can also to be considered as influential factors. The 
home health test kits are simple to perform, economical and time saving. Because of 
the differences in health care services received, distance of health care services and 
requirement of privacy and confidentiality, the market for these products is fast 
expanding. For older citizens living on fixed income, these kits may substitute for a 
physician. An individual can check his/her cholesterol and blood glucose in the 
privacy of his/her home which saves him/her time, money and stress.  
2.2 Cholesterol Tests and Their Functions 
Cholesterol is a soft, waxy substance present in the bloodstream in the form of 
lipids or fats. It also forms the cell membranes, some hormones and parts of tissues. A 
small amount of cholesterol is essential for the proper functioning of the body. A high 
level of cholesterol in the blood, also known as hypercholesterolemia, is a major risk 
factor for coronary heart disease. There are different kinds of lipoproteins in the body 
but the two kinds which indicate the risk of heart attack are “Low Density 
Lipoproteins” or LDL and “High Density Lipoproteins” or HDL (Medical 
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Encyclopedia, 2004; Cholesterol, 2004a; Cholesterol, 2004b; Cholesterol 2004d). 
Low density Lipoprotein is the major cholesterol carrier in the blood. It is also known 
as the “bad” cholesterol. HDL cholesterol also known as the “good” cholesterol 
carries the cholesterol from other parts of the body back to the liver. The liver 
removes cholesterol from the body. Triglyceride is a form of fat which is made in the 
body and also comes from the food that people eat. People having a high level of 
Triglyceride (>200 mg/dL) have a tendency to have high total cholesterol (> 240 
mg/dL), high LDL cholesterol (>160 mg/dL) and low HDL cholesterol (<40 mg/dL). 
Cholesterol is usually measured in milligrams (mg) of cholesterol per deciliter (dL) of 
blood. Some of the important cholesterol numbers are explained in Table 2.1. 
    Table 2.1: Important cholesterol numbers 
Total Cholesterol Level Total Cholesterol Category 
less than 200 mg/dL Desirable 
200-239 mg/dL Borderline high 
240 mg/dL and above High 
LDL Cholesterol Level LDL Cholesterol Category 
less than 100 mg/dL Optimal 
100-129 mg/dL Near optimal / above optimal 
130-159 mg/dL Borderline high 
160-189 mg/dL High 
190 mg/dL and above Very high 
HDL Cholesterol Level HDL Cholesterol Category 
less than 40 mg/dL(men < 37 mg/dL, 
Women <47 mg/dL) A major risk factor for heart disease 
40-59 mg/dL The higher the better 
60 mg/dL and above 
Considered protective against heart 
disease 
Triglyceride Level Triglyceride Category 
less than 150 mg/dL Desirable 
150-199 mg/dL Borderline high 
200 mg/dL -399mg/dL High 
400 mg/dL and above Very high 
 
The cholesterol numbers and their classifying categories have been taken from the 
third report of the National Cholesterol Education Program (NCEP) expert panel on 
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detection, evaluation and treatment of high blood cholesterol in adults (Adult 
treatment panel III) (Cleeman, 2001), official website of National Heart, Lung and 
Blood Institute, Diseases and Conditions Index (Cholesterol, 2004e), NIH-National 
Cholesterol Education Program-2001 recommendations (Hall, 2003) and (Medical 
Encyclopedia, 2002). 
 Cholesterol is one of the major risk factors for heart disease. Studies show that 
a 1% decrease in cholesterol level leads to 2% decrease in risk for heart disease 
(Cholesterol, 2004c). In the third report of the National Cholesterol Education 
Program (NCEP) expert panel on detection, evaluation and treatment of high blood 
cholesterol in adults (Adult treatment panel III), the members have updated clinical 
guidelines for cholesterol testing and management. They claim that adults above the 
age of 20 years should have a fasting lipoprotein profile (total cholesterol, high 
density lipoprotein, low-density lipoprotein and triglycerides) done every five years 
(Cleeman, 2001).  
 Due to the high demand to constant check on the cholesterol level and the 
increasing cost of medical care, the usage of home cholesterol testing kits is 
increasing. According to Pal (1998), the home cholesterol test kits had the highest sale 
growth rate of 28% in the year 1996.  These cholesterol testing kits are cheap and 
easy to use. Different types of cholesterol testing kits are available in the market. 
They can be broadly divided into two main categories – the laboratory based test and 
the home based tests. In the laboratory based test the user collects two to three drops 
of his blood using a lancet and places the blood on a special collection card to dry. 
The special collection card is then mailed to a laboratory for analysis. Results are 
mailed back within 4-5 days.  Some of the tests give the total cholesterol/HDL 
level/LDL level and the Triglyceride level also (Cholesterol monitors, 2004c). Most 
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of the tests that are performed at home give the total cholesterol level only. There are 
three types of home based tests – the meter based tests, the direct reading tests and the 
color comparison tests. In the meter based tests, a single drop of blood is collected 
using a lancet and placed on the cartridge. After two minutes the side tab is pulled to 
start the reaction. The results are read after 10-15 minutes as in a calibrated scale 
which resembles a thermometer. The results are compared to a chart to get the total 
cholesterol level (Cholesterol monitors, 2004d). In the direct reading cholesterol kits a 
chip is inserted to turn on the instrument. The test strip is inserted in to the instrument. 
A drop of blood is placed on a test strip using a capillary blood collector. The test 
results are displayed on the monitor (Cholesterol monitors, 2004a).  In the color 
comparison tests the blood drop is collected using a lancet. A single drop of blood is 
placed on the small circular test pad. The test pad is left for three minutes for the 
chemical reaction and development of color to take place. After three minutes the 
entire tab area on the test pad is discarded.  The drop of blood changes color. What we 
see is the changed drop of blood in the centre of a circular sliding chart or a color 
wheel. The color of the blood sample is compared to the colors in the chart to get the 
cholesterol level (Cholesterol monitors, 2004b). 
2.3 Human Factors in FDA  
 The FDA has taken aggressive steps to approach human Factors in Medical 
devices. It is encouraging manufacturers to apply Human Factors during design and 
development and is verifying this by evaluating the manufacturer’s design validation 
document as required by the Quality System Regulation. The FDA is working with 
manufacturers and distributors to help them in applying Human Factors in the design 
of new products. FDA’s Human Factors Program and Human Factors Engineering 
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Group are making efforts in this direction. The main goals of these programs are 
(FDA, 2003a); 
• To evaluate manufacturers' design validation documents required by the 
Quality System Regulation 
• To develop Guidance documents to help manufacturers understand and use 
human factors engineering  
• To educate manufacturers about the need for human factors programs;  
• To provide training and guidance for other FDA personnel about the 
importance of human factors in product design  
• To input human factors principles into medical device standards 
• Collaborate with professional organizations to educate the public about human 
factors and  
• To encourage users and manufacturers to report serious adverse incidents 
All the medical devices released in the market need to have pre-market 
approvals and pre-market notification 510(k). There are three main steps for obtaining 
market clearance from the Center for Devices and Radiological Health (CDRH). The 
first step is to ensure that the product to be marketed is a medical device according to 
the definition of a medical device in section 210(h) of federal Food Drug and 
Cosmetic Act (FD&C Act). In the second step, the manufacturer needs to determine 
how the FDA will classify the device. Unless exempted, FDA will classify the 
medical device. FDA classifies a device according to the amount of regulations 
necessary for reasonable assurance of safety and effectiveness. The three categories 
into which the FDA divides all the non-exempted medical devices are: 
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• Class I(General controls) – A device is classified under this category if there is 
evidence that the general controls of the device are sufficient to assure safety 
and effectiveness, example- elastic bandages, elastic gloves, hand held 
surgical instruments 
• Class II (Special controls) - A device is classified under this category if 
general controls alone cannot provide reasonable assurance of safety and 
effectiveness but has sufficient information to establish special controls to 
provide this assurance , example- powered wheel chairs, infusion pumps, 
surgical drapes 
• Class III (Pre-market Approval) – A device is classified under this category if 
the information about the device is insufficient to classify the device into Class 
I or Class II. A device is classified under this category if it  is  a life-sustaining 
or life-supporting device or it is used for preventing impairment of human 
health or presents potential unreasonable risk of illness or injury, example- 
implantable pacemaker pulse generators and endosseous implants (FDA, 
2002a ; Schultz, 1998). 
The third step is to development of data for submitting a marketing application to 
obtain clearance from FDA. For certain devices clinical performance data is required 
and the trial should be conducted according to FDA’s Investigational Device 
Exemption (IDE) regulation in addition to marketing clearance (FDA, 2003d). The 
flow chart in Figure 2.1 shows the process to be followed according to the new 510(k) 
(FDA, 2004a). 
 Most Class I and a few Class II devices are exempted from pre-market 
notification [510(k)] subjected to certain limitations. This decision has been taken in 
order to meet the requirements the Food and Drug Administration Modernization Act 
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Figure 2.1: New 510(k) paradigm as given by the FDA (FDA, 2004a) 
 12
of 1997 (FDAMA). The FDA has exempted over 800 generic types of Class I devices 
and 60 Class II devices from pre-market notification requirements. Devices exempted 
from 510(k) pre-market notification are: 
• Preamendment devices not significantly changed or modified, or 
• Class I/II devices specifically exempted by regulation (FDA, 2000). 
Though the exempted devices need not file a pre-market notification 510(k), 
they still need to meet other requirements for marketing which include Establishment 
Registration, Medical device listing, Labeling requirements and to fulfill Good 
Manufacturing Practices (GMP)/Quality System (QS) Regulation. 
2.4 Usability: Definition  
 
 When a new product/ system is designed, the main concern for the 
manufacturer is its acceptability. The product/system acceptability is defined as the 
ability of the system to fulfill the needs and requirements of the users. It is a 
combination of social acceptability and practical acceptability. The practical 
acceptability can be analyzed within various categories- cost, compatibility, reliability 
usefulness etc. usefulness can be defined as the extent to which the system can be 
used to achieve specific goal. It can be broken down into utility and usability. Utility 
is whether the functionality of the system can do what is needed and usability is how 
well the users use the functionality. The various considerations of usability are ease of 
use, efficient to use, few errors, ease to remember etc (Nielsen, 1993). The system 
acceptability can be better understood from the model shown in Figure 2.2. Usability 
is defined as the effectiveness, efficiency, and satisfaction with which specified users 
achieve specified goals in particular environments. 
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Figure 2.2: Flow chart showing the various divisions of system acceptability (Nielsen, 
1993) 
 
Each of the terms effectiveness, efficiency, and satisfaction can be further defined as: 
Effectiveness: The accuracy and completeness with which specified users can achieve 
specified goals in particular environments.  
Efficiency: The resources expended in relation to the accuracy and completeness of 
goals achieved.  
Satisfaction: The comfort and acceptability of the work system to its users and other 
people affected by its use (Dix et al, 1998).  
Usability is not a single, one-dimensional property of a product. It has multiple 
components and is associated with five attributes- learnability, efficiency, 
memorability, errors and satisfaction (Nielsen, 1993). 
Several changes have been occurring in the design of systems and devices for 
the elderly. The efficiency and safety of the health devices depends on their usability. 
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The factors defining the usability of these home health devices can be divided into 
three main categories-user characteristics, health care device characteristics and 
environmental conditions. The first consideration is the environmental conditions. 
Before designing a healthcare device the environment in which they will be used must 
be understood properly. For example, a home health testing kit for testing blood 
glucose or cholesterol will be used in the privacy of the house, offices, workplaces 
etc. Hence it should be considered as a portable device and size is an essential factor 
to be considered. The second consideration should be the user characteristics. It is 
always essential to define the characteristics of the users before thinking about the 
design specification of the medical device. The physical abilities and limitations, 
personal preference and cultural/ethnic background are few of the important aspects 
to be considered. Third, the device characteristics should be considered. Ease of use, 
size of device, appeal, cost, functionality and maintainability are few of the factors 
that come under this category. In the midst of satisfying all the usability factors the 
main purpose for which the device is being designed must not be lost (Garden-
Bonneau & Gosbee, 1997). The usability of a medical device can be better interpreted 
by Figure 2.3.  
2.5 Problems Faced by the Aged Population while Using Home Testing Devices 
 The Institute of Medicine states that as a result of the change in the 
mortality patterns, the populations of older adults (above the age of 65) constitute a 
major proportion of the American population (Sainfort et al., 2002). Lonergan & 
Krevans (1991) as quoted by Garden-Bonneau & Gosbee (1997) found that around 
$160 million was spent on healthcare for older adults suffering from chronic disorders 
and disabilities. The primary goal of many older adults is to maintain an independent 
life. 
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Figure 2.3: Factors defining the usability of home health devices (Garden-Bonneau & 
Gosbee, 1997) 
 
 
Research shows that as people age their movement control performance 
decreases. They take longer time to perform specific movements which are easily 
performed by younger adults. For example most of the cholesterol tests state “prick 
your finger, put a drop of blood on the test strip”. This may be easy for a young adult 
but older adults suffering from severe arthritis may find this task very difficult to 
perform (Fisk, 1999). Researchers have also found that elderly people do not 
understand or remember information that is essential for using devices efficiently 
(Morrow et al., 1988). They also have more difficulty in performing dual tasks than 
younger adults. For example, if an older adult needs to read instructions and perform 
the cholesterol test or blood glucose test simultaneously, he/she may skip instructions, 
repeat instructions, use the instructions in the wrong place or perform the test 
Device usage
Example:
Physical abilities
Personal preference
Cultural background
Environmental 
Conditions 
Example:
Physical 
Characteristics
Healthcare Device
Characteristics
Example:
Ease of use
Cost functionality
Maintainability
User
Characteristics
 16
incorrectly (Sit & Fisk, 1999).Vision and audition are the two primary modes of 
communicating information. Researchers have identified a variety of changes in the 
visual system (acuity, contrast, sensitivity and color discrimination) and cognitive 
function (working memory, symbol comprehension, language comprehension and 
prospective memory). Due to a decrease in the cognitive capacity there is a decrease 
in comprehension and compliance (Rousseau et al., 1998). Even though the home 
health testing kits may be designed for the older population considering their 
cognitive disabilities and physical limitations, the end result of the test depends on the 
correct interpretation of the instructions given to perform the test. Generally older 
adults try to match the instructions of a new device with their mental models of 
similar devices and hence try to put both of them together (instructions for the new 
device and their mental model of a similar device used) to use the novice device 
(Morrow et al., 1988). People better understand a step- by- step representation of the 
task being accomplished. The language used to write these instructions should be 
simple, explicit and unambiguous for better understanding.  According to Wright 
(1981), instructions are usable only when they match the capabilities and limitations 
of the user. 
The mode of instructions is also important. In a study done by Mykityshyn et 
al. (2002), it was found that the older adults who received video instructions had more 
knowledge about the device as compared to the older adults who received instructions 
through a written manual. They were faster, experienced lesser workload and the 
accuracy of performing the test was higher than the older adults who were trained 
using a manual. According to Kelly et al. (1991), with an advance in vitro diagnostic 
testing technology, there has been a reduction in the number of procedural steps. But 
this does not necessarily improve the overall effectiveness. They claim that 
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automating an easily learned task like wiping the extra blood from the test strip will 
not improve the effectiveness of the user-device system. On the other hand 
automating tasks such as blood sampling which are techniques-dependent and require 
training may improve the effectiveness of the user-device system. Performance testing 
is a useful method to detect procedural errors.  
Though designers may design the home health kits by taking into 
consideration all the usability aspects and the user limitations and disabilities, the 
reaction of the user after interpretation of the results can never be predicted. This 
depends on how much the user trusts his ability to perform the test and interpret the 
results and his confidence on the reliability of the test kit. 
2.6 Heart Attack Risk: Women Vs Men 
Heart disease is by far the leading cause of death in men as well as in women. 
According to the American Heart Association, each year cardiovascular disease 
claims the lives of about 448,000 men and 478,000 women. Nearly twice as many 
women die of heart disease and stroke as from all forms of cancer (Broad issues in 
women’s health, 2003). According to the Cholesterol Statistics of American Heart 
Association, (Cholesterol, 2004f), studies done on people aged 20 years and older 
showed that from the age of 50, a higher percentage of women than men have 
cholesterol level  greater than 200 mg/dL (borderline high- 200 mg/dL to 239 mg/dL). 
In spite of this proportion, women fear most that they will die of breast cancer. 
Although women develop heart disease 10 years later than men, they typically have 
more severe first strokes and remain more disabled. At the time of heart attack they 
are most likely to have other conditions like diabetes and high blood pressure which 
makes their recovery even more difficult. Women are not the only ones to overlook 
this serious problem. Even the physicians tend to overlook this problem in women. 
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The Centre for Disease Control and Prevention states that physicians often wait until 
women have a heart attack to advice them about preventive cure though women are 
less likely to survive a first attack than men (Women and heart attack, 1999). Around 
35% of the heart attacks in women go unnoticed or unreported (Giardina, 2000). In 
the past, most of the studies done in this field have been concentrated on men and the 
gender difference has been ignored completely. The studies that have included women 
as subjects suggest that most of the diagnosis, treatment and prevention of heart 
disease in men may not apply to women (Patlak, 1994). 
The most common and the most important sign/symptom of heart disease is 
chest pain or angina, occurring while a physically demanding task is being done. But 
chest pain is not a good diagnostic clue for heart disease in women as in men. Women 
are more susceptible to conditions such as heartburn or spasms of the esophagus or 
heart arteries which cause chest pain similar to angina. So, most of the chest pains 
complained by women are dismissed as heartburn. According to Dr. Weese, he once 
had a patient who complained of pain in the ear canal and once diagnosed, required a 
bypass surgery (Women and heart attack, 2002). Even though men and women are 
given the same treatment, women are less likely to survive. The main reasons for this 
difference is that the treatments and the medicines have been tested using the male 
subjects only. There have not been any studies to prove that the same treatments and 
medicines are effective for both genders. Few of the treatments cannot be performed 
on women because of their small size (small blood vessels and arteries). According to 
Dr. Ruth Merkatz of FDA, commonly used heart medications may not be as effective 
in women as they are in men because of their smaller body size, hormones and the fat 
content present in their body (Patlak, 1994).  
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 Following a low cholesterol diet will reduce the heart risk in women”- this 
statement is debatable as all the studies supporting low cholesterol diet have been 
done primarily using male subjects. Lowering the cholesterol lowers the HDL level as 
well as the LDL level. High HDL levels are much more protective in women than low 
LDL levels. It is not very clear whether lowering the total cholesterol is a good 
preventive measure in women with heart risk. (Patlak, 1994).  According to Dr. 
Ashish K. Jha, M.D. (a general medical fellow at Brigham and women hospital and 
the Harvard School of Health in Boston), heart disease is the biggest cause of death 
for women and there is a large gap between black and white women. According to a 
report from the American Heart Association, black women are more likely to have a 
coronary heart disease than white women. Black women have higher blood pressure, 
diabetes and high cholesterol. Poor control of cardiovascular disease could be one of 
the reasons for this difference. This cannot be attributed to economic status as in a 
study done by Dr Ashish K Jha, he found that black women used more expensive 
drugs than white women. He also found that women under higher risk were being 
under treated. Studies need to be done to narrow this gap between black and white 
women (Jha, 2003).  
 The answers to many of the questions concerning women and their heart 
attack risk remain unanswered. Research in heart disease in women started around 25 
years after research started on men. Hence research is still being done in this field. 
The FDA is also insisting that the new drugs and treatments being tested should 
represent the female population properly so that the drugs and treatments can be 
applied to both the genders. 
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3. RESEARCH OBJECTIVES AND HYPOTHESIS 
 
3.1 Research Objectives 
 From the conclusions drawn from the literature review, two research 
objectives have been framed. 
1. To find whether the instructions, procedure of the test and the ergonomic 
design of the cholesterol test kit affect the results (cholesterol numbers). 
2. To study differences in the future actions of people based on their gender and 
cholesterol results. 
3.2 Conceptual Model 
 
The popularity of home health testing kits has been increasing since their 
introduction in the 1940s. This increase in popularity may be influenced by several 
factors like the cost of the kit, cost of medical care, accessibility of health care, 
acceptance of the accuracy of the test results, ease of use features of the kit and the 
action of the patient after conducting the test and interpreting the results, refer to 
Figure 3.1: Conceptual model. These factors can influence the usage of any home 
health test kit irrespective of what it is testing. In a study done by Pal in 1998, he 
found that the sale growth rate of home cholesterol testing was the highest at 28%. 
Since then, the popularity of the home cholesterol test kits has been increasing. 
According to the cholesterol statistics published by the American Heart Association 
(Cholesterol, 2004f), an estimated 105 million American adults have total blood 
cholesterol value of 200 mg/dL and above. Of these, 42 million Americans have level 
of 240 mg/dL and above. In adults, the total blood cholesterol levels of 200mg/dL- 
239mg/dL is considered as borderline risk and 240mg/dL and above are considered as 
high risk cholesterol numbers. Based on these statistics, the present study concentrates 
on the home cholesterol test kits only.  
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 Instructions using the home health test kits directly influence the accuracy in 
performing the test and hence the results obtained by performing the test.  The wrong 
interpretation of instructions can give different results and hence put the health of the 
patient at risk. The correct interpretation of the instructions also depends on the age 
and education of the person. Vision and audition are the two primary modes of 
communicating information. Researchers have identified a variety of changes in the 
visual system (acuity, contrast, sensitivity and color discrimination) and cognitive 
function (working memory, symbol comprehension, language comprehension and 
prospective memory) as a person ages. Due to a decrease in the cognitive capacity 
there is a decrease in comprehension and compliance (Rousseau et al., 1998). The 
education level of the users may be less than the readability level of the instructions. 
Even though the instructions maybe interpreted correctly the design of the kit may 
hinder the performance of the test. For better portability these home health test kits 
are often made as small as possible and as such there is a possibility that the patient 
pushes the wrong buttons. Hence the ergonomic design of the kit also influences the 
outcome or result of the test. Interpretation of results is another major factor to be 
considered. In the direct display test kits, the cholesterol numbers are displayed on the 
digital display screen but in the color comparison and meter based test kits, the 
cholesterol number is interpreted by comparing the length of the colored solution or 
the color on the card (like in Chemcard) to get the cholesterol numbers. In a study 
done by the manufacturers of Chemcard, it was found that more than 50% of the 
participants wrongly interpreted the cholesterol numbers (Chemcard, 2004).  
According to the National health and nutrition examination survey III 
(NHANES III) 1988-94, conducted by The Centers for Disease Control/National 
Center for Health Statistics, the risk of Coronary Heart Disease due to high blood 
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cholesterol differs according to race and ethnicity. It was found that among the non-
Hispanic blacks ages 20-74, the age adjusted prevalence of total blood cholesterol 
levels over 200 mg/dL was 45 percent of men and 46 percent of women. They also 
found that 15 percent of men and 18 percent of women had blood cholesterol levels of 
240 mg/dL or higher (total blood cholesterol levels of 200 – 239 mg/dL are 
considered as borderline risk cholesterol numbers and 240 mg/dL and above are 
considered as high risk cholesterol numbers). The results of the survey also stated that 
the non-Hispanic blacks were a high CHD risk population next to the Mexican 
Americans (Cholesterol, 2004f). If non-Hispanic blacks from lower socio-economic 
background with lower levels of education are considered, the risk of high cholesterol 
maybe more.    
The home health testing kits were introduced in the market to help people take 
better care of their health and also reduce the cost of health care. After performing the 
test and interpreting the results the question that now arises is, “What do patients do 
with these results?” If the result shows that their health is at risk do they visit a doctor 
or take home curative measures like controlling their diet or do they simply ignore the 
results. If the results show that they are fine and do not have any health problems, do 
they trust the results and accept that they are healthy or do they still go and visit the 
doctor regularly.  This is a question which does not have a single answer. The 
psychology of the person plays a very important role here. The knowledge of the 
patient about their risk factors is also important here. For example women in general 
do not consider heart attack as a women’s disease. So if they get a test result showing 
that they have a high risk of heart attack what will be their reaction? Similarly it has 
been found that African-American women are more prone to heart attack than white 
American women. Will they react differently than their counterparts? Another 
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question that can be asked in this context is whether men and women will react in the 
same manner when they get similar results. This is one of the major factors that 
influence the usage of home health test kits which cannot be physically measured.  
The conceptual model of the factors affecting the usage of home health testing 
kits and their interdependence has been graphically represented in Figure 3.1. 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Conceptual model of the usage of home cholesterol test kit 
 
This research project will investigate ease of use factors for the home cholesterol tests 
actions of patients upon receipt of the results, and clinical accuracy of the kits. Each 
of the hypotheses have been highlighted in Figure 3.1. 
3.3 Research Hypothesis 
From the literature and the conceptual model the following three hypotheses have 
been defined. 
H1: No difference exists in the cholesterol reading between the two test kits and the 
clinical laboratory results.  
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H2: No difference exists in use of information from cholesterol test kit results by 
gender.  
H3: No difference exists between the user performance of cholesterol digital test and 
cholesterol meter based test. 
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4. METHOD 
4.1 Experimental Design 
A study was conducted at Louisiana State University in Baton Rouge. Factors 
measured were usability questionnaire scores for each test kit, the number and type of 
errors committed by participants while using the cholesterol test kits, future healthcare 
decision of the participants based on the cholesterol test results, and the accuracy of 
the test kits results when compared to clinical laboratory results.  
4.2 Participants 
 
Thirty individuals consisting of 15 males and 15 females from different economic 
backgrounds and different education levels employed by Louisiana State University 
participated in the study. The only basis for excluding people from the study was their 
unwillingness to participate in the study. 
4.3 Testing Materials and Tools  
The tools used in the study are the demographic questionnaire (Appendix A), 
Usability questionnaire (Appendix B and Appendix C), Comparison Questionnaire 
(appendix D), the post test questionnaire (Appendix E) and Video analysis worksheet 
(Appendix F). The demographic questionnaire included questions on age, gender, 
education level, annual income, type of medical insurance and information on the 
knowledge and usage of the home health test kits. The usability questionnaire 
includes questions on the test kit instructional material, the experience of the patient 
while using the test kit and subjective comments of the patient on the test kit. In the 
comparison questionnaire, the patients were asked to rate each of the two kits on the 
given criteria. In the post test questionnaire, participants were asked their about future 
health decisions they would make based on the tests results and their willingness to 
use the home cholesterol test kit in the future. Additionally, participants were asked 
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(Part –B) to compare the home cholesterol test and the laboratory results. The change 
in the future medical decision of the patient due to the availability of the laboratory 
results was studied through the questionnaire. The Video analysis worksheet includes 
the step-by-step procedure to be followed to perform the home cholesterol test, the 
time taken to perform each step, and the errors committed while performing the test. 
Accuchek® Instant plus®  cholesterol test kit manufactured by Roche Diagnostics 
and Home Access® Instant Cholesterol Test kit manufactured by Home Access will 
be used as the two cholesterol test kits to be compared. 
4.4 Procedure 
 
All the participants were asked to complete the demographic questionnaire 
(Appendix A). The participants were randomly assigned one of the two home 
cholesterol test kits and asked to check their cholesterol level. No instruction was 
provided as this was an out-of-the-box experiment. Their interaction with the 
cholesterol test kits was recorded using a Video Camcorder. After checking their 
cholesterol level they were asked to answer the Usability questionnaire (Appendix B 
or Appendix C) based on the cholesterol test they used. Participants were later asked 
to complete the post results questionnaire (Appendix E) to assess their future 
healthcare decision based on the cholesterol results of the first test they used. The 
participants were given the other cholesterol test kit and were asked to check their 
cholesterol level again. Once again, they answered the usability questionnaire for the 
cholesterol test kit used. After they checked their cholesterol level using both kits, the 
participants were asked to complete the comparison questionnaire (Appendix D). The 
participants were taken to the LSU student health center where a blood sample was 
drawn by the medical technician in the laboratory. This blood sample was then 
transported to Pennington Biomedical Research Center for analysis. Laboratory 
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cholesterol levels were obtained which included the complete cholesterol value along 
with the HDL and LDL values. After the participants receive their cholesterol 
numbers from the Pennington, a follow on study was conducted. The participants 
were asked to complete Part-B of the post results questionnaire to evaluate the 
accuracy of the home cholesterol test results, change in their future health plan, and 
any change in their opinion on the home cholesterol test kits. The step by step 
procedure of the study is represented in the Figure 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Flow chart of the experimental procedure 
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5. RESULTS 
Experimental analysis was conducted using SAS 9.1.2 and JMP (version 5). 
Analysis of variance (ANOVA), T-tests and Nominal logistic regression were 
performed on the data using a significance level of α = 0.05. Correlation studies were 
conducted to compare the laboratory cholesterol results and the home cholesterol test 
results and also to compare the total significant errors committed while using each of 
the test kits and the error in the test kit reading.  
As discussed in the procedure section, thirty participants, fifteen male and 
fifteen female, participated in the study. The interaction of the participants with the 
test kits was video-taped to compute the number of errors and the type of errors 
committed by them while using each of the test kits. During the study, two 
participants refused to use the Accuchek® Instant plus® (digital) test kit as they 
found the procedure to be very complicated. One Home Access® Instant Cholesterol 
Test kit did not work although the participant followed the instructions and performed 
the test as per the instructions. Three participants did not use enough blood for the 
Home Access® Instant Cholesterol Test kit and their test results failed completely. 
The two participants who refused to use the Accuchek® Instant plus® test kit did not 
rate the meter in the post questionnaire. They were deleted from the analysis. For the 
analysis of future healthcare decision based on the cholesterol test kit results, all the 
participants who were already visiting a doctor were excluded. Demographic statistics 
of the study are shown in Table 5.1. 
Appropriate parametric and non-parametric analyses were performed on the 
data. Before conducting parametric analysis, test for normality and homogeneity of 
variance were performed to check the normality of the data. According to Neter, 
Wasserman & Kutner (1985), “the F test for equality of factor level means is but little  
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Table 5.1: Demographic Statistics       
 Demographics                           Number 
Number of participants         30 
Number of male participants         15 
Number of female participants        15 
Number of participants between 
Below 30 years          1 
31 – 40 years          4 
41 – 50 years         12 
51 – 60 years         10 
61 – 70 years         3 
Number of participants used Accuchek® Instant plus® first   16 
Male            8 
Female          8 
Number of participants used Home Access® Instant Cholesterol Test first  14 
Male            7 
Female          7 
Number of participants quit Accuchek® Instant plus®    2 
Number of participants quit Home Access® Instant Cholesterol Test  0 
Number of test kits failed to give results      1 
Accuchek® Instant plus®        0 
Home Access® Instant Cholesterol Test      1 
Number of times kits yielded no results      3 
Accuchek® Instant plus®        1 
Home Access® Instant Cholesterol Test      2 
Number of participants answered usability questionnaires    30 
Accuchek® Instant plus®         30 
Home Access® Instant Cholesterol Test      30 
Number of participants answered comparison questionnaire    30 
Number of participants answered post usability questionnaire   28 
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effected by lack of normality. The F-test is a robust test against departures from 
normality.” Hence, normality is not a major concern. However, homogeneity of 
variance is essential for testing ANOVA (Neter et. al, 1985). All data as will be 
discussed was found to be homogeneous. Even though the ANOVA test is robust to 
non-normality, if the data failed the normality test, the nonparametric Kruskal Wallis 
test was also performed. In all cases, the conclusion between the ANOVA and 
nonparametric ANOVA yielded the same conclusion. Thus, only the parametric 
analysis is reported. All non-parametric results are included in Appendix G. A 
nominal logistic regression was performed for the analysis for the evaluation of the 
future healthcare decision. 
5.1 Hypothesis 1   
The first hypothesis states that no difference exists in the cholesterol reading between 
the two test kits and the clinical laboratory results.  
A stepwise selection was performed to determine which factors (e.g., gender, 
kit) should be included in the analysis. At a reduced α=0.1 level of significance, 
where the model accepted a variable, it was concluded that gender should not be 
included in the model, thus gender was excluded as a variable and the data collapsed 
to evaluate the errors between test kit results and laboratory results irrespective of 
gender. The Accuchek® Instant plus® test kit displays all the cholesterol results 
between 150 mg/dL and 300 mg/dL. If the cholesterol level is <150 mg/dL it displays 
“Low” and if the cholesterol level is higher than 300 mg/dL it displays “high”. 
Similarly, Home Access® Instant Cholesterol Test cannot measure cholesterol levels 
lower than 120. A few of the participants had very low cholesterol, lower than 120. 
Their test kit results showed “low” in the case of Accuchek® Instant plus® and <120 
for Home Access® Instant Cholesterol Test. The accuracy of such results for 
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Accuchek® Instant plus® and Home Access® Instant Cholesterol Test cannot be 
determined as the test results can vary from 149 and 119 respectively to their actual 
cholesterol level. Two cases have been considered for such data. In the first case (case 
1), all the “<150” values have been approximated to 149 mg/dL and “<120” to 119 
mg/dL. In the second case (case 2), “<150” and “<120” have been approximated to 
the laboratory values or 149/119 whichever is closer. A two sample one way ANOVA 
was performed. The independent variable was the type of test kit and the dependent 
variable was the error between the test kit results and the laboratory results. The 
sample size was 54. Participants who did not have a test result were excluded from the 
study. The results of both cases for evaluation follow. 
5.1.1 Case 1 
• Model Assumptions 
Tests for normality, Shapior-Wilkes’test, and homogeneity of variance, 
Levene’s test, were conducted. Shapiro-Wilkes found the data to be non-
normal (W= 0.739197, p <0.001). Levene’s test showed that the homogeneity 
of variance can be assumed (F (1, 52) = 2.19, p = 0.1453). As discussed 
earlier, parametric tests were used since homogeneity of variance was found 
to exist regardless of the non-normality. 
• Analysis of Variance (ANOVA) 
 The results of the ANOVA are tabulated in Table 5.2. The mean error in 
cholesterol reading while using the Accuchek® Instant plus® test kit is 
25.14815 and the mean error in cholesterol reading while using Home 
Access® Instant Cholesterol Test kit is 35.59259. The results show that there 
is no relationship between the type of test kit used and the errors between the 
test kits results and the laboratory results in case 1. Thus, there does not 
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appear to be a relationship between the type of test kit used and the errors 
between the test kit and the laboratory results. 
          Table 5.2: Case 1: <150 = 149 mg/dL and <120 = 119 mg/dL 
 
 
                
             
 
Kruskal Wallis test, ANOVA for non-parametric data, was performed as the 
data set failed the normality test. The results (Appendix G) of the Kruskal 
Wallis test gave the same conclusion as the ANOVA. 
5.1.2 Case 2 
• Model Assumption  
Tests for normality, Shapior-Wilkes’test, and homogeneity of variance, 
Levene’s test, were conducted. Shapiro-Wilkes found the data to be non-
normal (W= 0.722185, p <0.001). Levene’s test showed that the homogeneity 
of variance can be assumed (F (1, 52) = 2.25, Pr > F = 0.1396).  
• Analysis of Variance (ANOVA) 
The results of ANOVA are tabulated in Table 5.3. 
Table 5.3: Case 2: <150 and <120 = laboratory results or 149/119 whichever is      
closer. 
 
Source DF Sum of squares Mean square F – value Pr > F 
Model 1  2802.24074  2802.24074  2.29  0.1366 
Error 52 63749.18519  1225.94587   
Corrected total 53   66551.42593   
Source DF Sum of squares Mean square F – value Pr > F 
Model 1 1472.66667 1472.66667 1.23  0.2721 
Error 52 62145.92593 1195.11396  
Corrected total 53  63618.59259   
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The mean error in cholesterol reading while using the Accuchek® Instant 
plus® test kit is 20.33334 and the mean error in cholesterol reading while 
using Home Access® Instant Cholesterol Test kit is 34.74074.The results 
show that there is no relationship between the type of test kit used and the 
errors between the test kit results and the laboratory results.  
 Equating <150 to 149 mg/dL and <120 to119 mg/dL or equating them to the 
laboratory values does not effect the results of the ANOVA or the Kruskal Wallis. 
The end result was the same; there appears to be no relation between the type of test 
kit used and the error between the test kit and the laboratory results. From the results 
of the statistical analysis, there is strong evidence supporting hypothesis 1. 
5.1.3 Correlation between Laboratory Results and Test Results 
A correlation analysis was performed between the laboratory test results and 
test kit results, and between the two test kit results. The Accuchek® Instant plus® test 
kit displays all the cholesterol results between 150 mg/dL and 300 mg/dL. If the 
cholesterol level is <150 mg/dL it displays “Low” and if the cholesterol level is higher 
than 300 mg/dL it displays “high”. Similarly, Home Access® Instant Cholesterol Test 
cannot measure cholesterol levels lower than 120. A few of the participants had very 
low cholesterol, lower than 120. Their test kit results showed “low” in the case of 
Accuchek® Instant plus® and <120 for Home Access® Instant Cholesterol Test. The 
accuracy of such results cannot be determined as the test results can vary from 149 to 
their actual cholesterol level. Two cases have been considered for such data. In the 
first case, all the <150 values have been approximated to 149 mg/dL and <120 to 119 
mg/dL. In the second case, <150 and <120 have been approximated to the laboratory 
values or 149/119 whichever is closer. The correlation analysis was performed for 
both the cases to see if there is a difference in the Pearson correlation for the two 
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cases. The correlation analysis was conducted by gender and also ignoring gender. 
The correlations are tabulated in Table 5.4. 
From the results of the correlation analysis, the laboratory results and Accuchek® 
Instant plus® test results are highly correlated for both male and female subjects. 
Even if the gender is ignored the laboratory results and the Accuchek® Instant plus® 
results are highly correlated.  
Table 5.4: Correlation between Laboratory results and test kit results.  
 
For the laboratory and the Home Access® Instant Cholesterol Test results, there is 
significant correlation for female subjects for both the cases. There is no significant 
correlation for male subjects for both the cases. When the gender is ignored, once 
again the test kits and the laboratory results are significantly correlated.  
 
 b/w lab results and individual test kit b/w test kits 
 Accuchek® Instant 
plus® &Laboratory 
results 
Home Access® 
Instant Cholesterol 
Test & Laboratory 
results 
Accuchek® Instant plus® &  
Home Access® Instant 
Cholesterol Test 
  <150=149 <140=lab or 
149 
<120=119 <120=lab 
or 119 
<150=149 
& 
<120=119
<150 & <120 = 
lab or 149/119 
Female 0.71938 
(p=0.0037) 
0.80990 
(p=0.0004)
0.54219 
(p=0.0452)
0.58021 
(p=0.0296)
0.22019 
(p=0.4699)
0.36195 
(p=0.2243) 
Male 0.81107 
(p=0.0008) 
0.91533 
(p=<0.0001)
0.28840 
(p=0.3393)
0.31361 
(p=0.2968)
-0.15217 
(p=0.6551)
0.07287 
(p=0.8314) 
Total  0.73752 
(p=<0.0001) 
0.84110 
(p=<0.0001)
0.38881 
(p=0.0450)
0.42055 
(p=0.0289)
0.11322 
(p=0.5984)
0.27500 
(p=0.1934) 
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5.2 Hypothesis 2  
The second hypothesis states that no differences exist in use of information from 
cholesterol test kit results by gender.  
For the purpose of analysis, all the subjects who were already visiting a doctor 
were excluded from the data set. Participants were given three options: (1) change in 
lifestyle, (2) visit a doctor and (3) no change in lifestyle/ not visiting a doctor for their 
response to the future healthcare decision, the dependent variable. Their decision was 
based on the results of the first test kit used. The independent variables were gender, 
test results and their interaction. Since the response variable, future health care 
decision, is nominal, a nominal logistic regression was performed. The analysis was 
performed on eleven male and eleven female subjects. A whole model test was 
performed to check the validity of the test. The results of the test (χ2 (0.05, 6) = 
18.7164, Pr> χ2 = 0.0047) show that the model is a good fit for the data. Wald test for 
individual effects was performed. The results are tabulated in Table 5.5 below 
Table 5.5: Results of Wald test for individual effects – gender is considered as an 
effect. 
 
Source Nparm DF Wald Chi-square Pr > ChiSq 
Gender 2 2 0.29473882 0.8630 
Test results  2 2 0.66394332 0.7175 
Gender*test results  2 2 0.36012879 0.8352 
 
The p values for each of the independent variables show that there is no effect on any 
of the individual variables on the future healthcare decision by themselves and thus 
the whole model is the best description of the effect. A Table for the predicted P value 
for each option when the cholesterol level is in the range of 119 mg/dL and 254 
mg/dL was drawn to find the probability of the subject choosing a specific future 
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healthcare plan on the basis of his/her gender and test results. The probabilities are 
tabulated in Table 5.6 and plotted in Figure 5.1 below.        
Table 5.6: Predicted P values for each option when the cholesterol level is in the 
range of 119 mg/dL and 254 mg/dL 
 
Gender Test results change in 
lifestyle 
visit a doctor no change in 
lifestyle/ not 
visiting a 
doctor 
female 119 2.5937E-49 0.03802754 0.96197246 
female 152.75 4.48E-30 0.12841984 0.87158016 
female 186.5 6.3252E-11 0.35449685 0.64550315 
female 220.25 1 1.0958E-09 5.3533E-10 
female 254 1 2.1424E-28 2.8081E-29 
     
male 119 0.14075929 0.30011077 0.55912994 
male 152.75 0.37415823 0.24806484 0.37777693 
male 186.5 0.68361797 0.14093822 0.17544381 
male 220.25 0.88547097 0.05676688 0.05776215 
male 254 0.96476992 0.01923313 0.01599695 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Graph showing the predicted P values for men and women 
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From Table 5.6 it is observed that regardless of the cholesterol level of the 
participant, there is a relatively low probability that a patient would chose to visit a 
doctor. By looking at the predicted P values one sees a trend in the probabilities 
associated with the decision. As the cholesterol increases, the decision tends to move 
from a do nothing decision to a change in lifestyle. The percentage choosing to visit a 
physician stays relatively constant across all levels of cholesterol.  
From Figure 5.1 it is observed that the trend in the predicted P values is 
different for male and female subjects. Both men and women said they preferred not 
to change their lifestyle at lower cholesterol levels. As the cholesterol level increases 
the predicted probabilities decreases steadily. A sharper decline is observed in women 
when compared to men. Both men and women have low predicted probabilities for 
choosing to visit a doctor regardless of the cholesterol level. Infact, for men the 
probabilities decline as the cholesterol level increases. As the cholesterol level 
increases, men and women said they preferred to change their lifestyle. A gradual 
increase in predicted probabilities is observed for men. At 186.5 mg/dL the predicted 
probability for men is 0.68361797 and at 220.25 mg/dL it is 0.88547097. The 
predicted probability for women sharply increases from 6.3252E-11 to 1 as the 
cholesterol level increases from 186.5 mg/dL to 220.25 mg/dL. From Figure 5.1 it is 
observed that men and women have different opinions on their future healthcare 
decision.  
5.3 Hypothesis 3 
 The third hypothesis states that no differences exist between the user performance of 
cholesterol digital test and cholesterol meter based test.  
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The user performance was assessed with the aid of questionnaires and video 
analysis. Responses were collected through three different questionnaires – usability 
questionnaire, comparison questionnaire and post result questionnaire.  
5.3.1 Usability Questionnaire  
The participants answered a usability questionnaire after using each of the test 
kits. A stepwise selection was performed to see whether order of test kit used and 
gender of the participant had an effect on the responses. At α=0.1 level of 
significance, where the model accepted variable, it was found that order had an effect 
on the response (p= 0.0144), but gender did not have an effect. For analysis, the 
scores of those subjects who used the respective test kits, Accuchek® Instant plus® 
and Home Access® Instant Cholesterol Test, first were considered. The usability 
scores were compared irrespective of gender, for each test kit. The dependent variable 
is the response score and the independent variable is the type of meter. The sample 
size was 30. A two-sample set-up one way ANOVA was performed 
• Model Assumption  
A normality test was conducted to check the normality of the data set. The 
Value of Shapiro-Wilkes was very insignificant at W = 0.78318 and p = 
<0.001. A Levene’s test for homogeneity of variance was performed. The test 
results show that the homogeneity of variance exists (F (1, 28) = 1.87, Pr > F 
= 0.1826).  
• Analysis of Variance (ANOVA)  
The results have been tabulated in Table 5.7. The mean usability score for 
Accuchek® Instant plus® test kit is 30.9375 and the mean usability score for 
Home Access® Instant Cholesterol Test kit is 33.14286. The results show 
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that the response of the usability questionnaire does not depend on the type of 
test kit being rated. 
          Table 5.7: Results of ANOVA – Usability questionnaire results. 
Source DF Sum of squares Mean square F - value Pr > F 
Model 1 36.314881  36.314881  0.30  0.5873 
Error 28 3372.651786 120.451849   
Corrected total 29  3408.966667   
 
Kruskal Wallis test, ANOVA for non-parametric data, was performed as the 
data set failed the normality test. The results (Appendix G) of the Kruskal 
Wallis test gave the same conclusion as the ANOVA. There is no relation 
between the type of test kit being rated and the response of the usability 
questionnaire. 
5.3.2 Comparison Questionnaire 
 After testing their cholesterol using both the test kits, the participants 
answered a comparison questionnaire in which they were asked to rate the two test 
kits against each other. A stepwise selection was performed to see whether order of 
test kit used and gender of the participant had an effect on the responses. At α=0.15 
level of significance it was found that order had an effect on the response (p= 0.1136) 
but gender did not have an effect. For the analysis, the scores of those subjects who 
used the respective test kits, Accuchek® Instant plus® and Home Access® Instant 
Cholesterol Test, first were considered. The usability scores were compared 
irrespective of gender, for each test kit. The dependent variable is the response score 
and the independent variable is the type of meter. The sample size was 30. A two-
sample set-up one way ANOVA was performed.  
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• Model Assumptions 
A normality test was conducted to check the normality of the data set. The 
Value of Shapiro-Wilkes was very insignificant at W = 0.760658 and p = 
<0.001. A Levene’s test for homogeneity of variance was performed. The test 
results show that the homogeneity of variance exists (F (1, 28) = 1.93, Pr > F 
= 0.1755).  
• Analysis of Variance (ANOVA)  
The results have been tabulated in Table 5.8.  
             Table 5.8: Results of ANOVA – comparison questionnaire results 
 
The mean usability score for Accuchek® Instant plus® test kit is 28.625 and 
the mean usability score for Home Access® Instant Cholesterol Test kit is 
34.07143.The results show that the response of the comparison questionnaire 
does not depend on the type of test kit being rated. Kruskal Wallis test, 
ANOVA for non-parametric data, was performed as the data set failed the 
normality test. The results (Appendix G) of the Kruskal Wallis test gave the 
same conclusion as the ANOVA. There is no relation between the type of test 
kit being rated and the response of the comparison questionnaire. 
 
 
Source DF Sum of squares Mean square F - value Pr > F 
Model 1 221.488095 221.488095  1.70  0.2032 
Error 28  3652.678571 130.452806   
Corrected total 29  3874.166667   
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5.3.3 Post – Questionnaire   
After getting the laboratory test results, the participants were again asked to 
answer a usability questionnaire. A stepwise selection was performed to see whether 
order of test kit used, and gender of the participant had an effect on the responses. At 
α=0.15 level of significance it was found that neither order nor gender had an effect 
on the response. For the analysis, the scores of all the participants irrespective of the 
order of use and the gender of the participant, was considered. The dependent variable 
is the response score and the independent variable is the type of meter. Two 
participants did not rate the Accuchek® Instant plus® meter as they quit the test. The 
sample size was 58. A two-sample set-up one way ANOVA was performed.  
• Model Assumptions 
A normality test was conducted to check the normality of the data set. The 
Value of Shapiro-Wilkes was very insignificant at W = 0.947175 and p = 
0.0135. A Levene’s test for homogeneity of variance was performed. The test 
results show that the homogeneity of variance exists (F (1, 56) = 0.11, Pr > F 
= 0.7453). 
• Analysis of Variance (ANOVA) 
 The results have been tabulated in Table 5.9.  
          Table 5.9: Results of ANOVA – post questionnaire results 
Source DF Sum of squares Mean square F - value Pr > F 
Model 1  52.155172 52.155172  2.21   0.1423 
Error 56   1318.965517 23.552956   
Corrected total 57   1371.120690   
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The mean usability score for Accuchek® Instant plus® test kit is 11.7931 and 
the mean usability score for Home Access® Instant Cholesterol Test kit is 
13.68966.The results show that the response of the post - questionnaire does 
not depend on the type of test kit being rated. Kruskal Wallis test, ANOVA 
for non-parametric data, was performed as the data set failed the normality 
test. The results (Appendix G) of the Kruskal Wallis test gave the same 
conclusion as the ANOVA.  
There is no relation between the type of test kit being rated and the response of the 
post questionnaire. From the statistical analysis of the three questionnaire studies 
there is strong evidence supporting hypothesis 3. 
5.3.4 Video – Analysis 
 The interaction of the participants with the test kits was also recorded to 
assess the number of errors and the type of errors committed during the interaction. 
Errors have been classified into four different categories – commission errors, 
omission errors, timing errors and sequence errors based on Swain and Guttmann’s 
(1983) error taxonomy (Appendix I). Errors were also classified as significant and 
non-significant errors. Errors which influence the test result are called as significant 
errors and the errors which do not influence the test results are called non-significant 
errors. A list of significant errors for each of the test kits is given in Table 5.10. To 
validate the video analysis, 30 random data points were selected. Each data point 
consisted of a 5 minute randomly generated interval.  The videos were re-run and the 
errors committed during this time interval were tabulated.  The errors committed 
during the total video analysis and the validation video analysis was compared using 
Pearson correlation. 
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  Table 5.10 Significant errors in each of the test kits  
Accuchek® Instant plus® Home Access® Instant Cholesterol Test 
Not wiping off the first drop of blood Not wiping off the first drop of blood 
Improper application of blood on the 
yellow test pad of the test strip 
Improper application of blood in the well. The 
well should be filled with blood until the 
black circle is completely covered 
Not closing the protective cover within 
5 seconds 
Not completing the application of blood in the 
well within 5 minutes 
 
Not waiting for at least 2 minutes and not 
more than 4 minutes before pulling the plastic 
tab 
 Improper tapping of the test meter after pulling the plastic tab. 
 
The results of the correlation analysis are tabulated in Table 5.11. 
Table 5.11: Results of correlation Analysis for video analysis validation.  
  Total Commission Omission Timing 
Correlation 
(p-value) 
0.85466 
(<0.0001) 
0.91700 
(<0.0001) 
0.82916 
(<0.0001) 
0.74536 
(<0.0001) 
 
The results of the Pearson correlation show that there is a significant correlation 
between the two analyses results. As a result of the correlation of 0.70 or greater, the 
researcher is confident in the findings.  
5.3.4.1 Video Analysis Results 
A paired t– test was performed to compare the total errors committed by each 
participant while using each kit. The results of the t-tests are tabulated in Table 5.12.  
Comparing the total errors committed while using each of the two test kits, the mean 
errors committed while using the Accuchek® Instant plus® test kit is 3.5334 and the 
mean errors committed while using Home Access® Instant Cholesterol Test kit is 
1.9667.             
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Table 5.12: Results of paired T-Test for total errors and total significant errors. 
 
  
 
 
There is strong evidence that the two means are not equal. Hence, the number of 
errors committed while using Accuchek® Instant plus® were significantly more than 
the number of errors committed while using Home Access® Instant Cholesterol Test.  
Comparing the total significant errors committed while using each of the two test kits, 
the mean errors committed while using the Accuchek® Instant plus® test kit is 
1.0667 and the mean errors committed while using Home Access® Instant 
Cholesterol Test kit is 1.9667. There is strong evidence that the two means are not 
equal. Hence, the number of errors committed while using Home Access® Instant 
Cholesterol Test is significantly more than the number of errors committed while 
using Accuchek® Instant plus®. 
Paired t-tests were performed to compare the commission errors, omission 
errors and the timing errors committed while using each of the two test kits. The 
results of the T-tests are tabulated in Table 5.13. 
 Table 5.13: Results of paired T-tests for the different categories of errors 
  Commission Omission Timing 
Difference DF t Value Pr > |t| t Value Pr > |t| t Value Pr > |t| 
acct - inst  29 6.29 <0.0001 -1.72 0.0960 -3.79 0.0007 
 
 
 
  Total Errors Total Significant errors 
Difference DF t Value Pr > |t| t Value Pr > |t| 
acct - inst  29 3.91 0.0005 -3.46 0.0017 
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• Commission Errors 
The mean errors committed while using the Accuchek® Instant plus® test kit 
is 2.9 and the mean errors committed while using Home Access® Instant 
Cholesterol Test kit is 0.8334. There is highly significant evidence that the 
two means are not equal. Hence, the number of commission errors committed 
while using Accuchek® Instant plus® significantly more than the number of 
commission errors committed while using Home Access® Instant Cholesterol 
Test.   
• Omission Errors 
Comparing the omission errors committed while using each of the two test 
kits, the mean errors committed while using the Accuchek® Instant plus® test 
kit is 0.334 and the mean errors committed while using Home Access® 
Instant Cholesterol Test kit is 0.5. There is slightly significant evidence that 
the two means are not equal. Hence, the number of omission errors committed 
while using Accuchek® Instant plus® were weakly significantly less than 
using Home Access® Instant Cholesterol Test.  
• Timing Errors 
Comparing the timing errors committed while using each of the two test kits, 
the mean errors committed while using the Accuchek® Instant plus® test kit 
is 0.2 and the mean errors committed while using Home Access® Instant 
Cholesterol Test kit is 0.6334. There is highly significant evidence that the 
two means are not equal.  
Hence, the number of commission errors committed while using Accuchek® Instant 
plus® significantly less than the number of commission errors committed while using 
Home Access® Instant Cholesterol Test. 
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5.4 Post Hoc Analysis 
 
5.4.1 Correlation between the Significant Errors Committed while Using the Test Kits 
and the Difference Between the Laboratory Results and Test Kit Results 
 
A correlation analysis was performed between the significant errors 
committed while using each of the test kits and the difference between the laboratory 
results and each of the test kit results. Two different cases were considered for each 
kit. For Accuchek® Instant plus®: 
• Case 1 – All “<150” values have been approximated to 149 
• Case 2 – All “<150” values have been approximated to either the laboratory 
results or 149, whichever is closer. 
For Home Access® Instant Cholesterol Test: 
• Case 1 – All “<120” values have been approximated to 119 
• Case 2 – All “<120” values have been approximated to either the laboratory 
results or 119, whichever is closer. 
The results of the correlation analysis are tabulated in Table 5.14 below. 
Table 5.14 Correlation analyses between the significant errors and errors in test 
results 
 
 Accuchek® Instant plus® Home Access® Instant 
Cholesterol Test 
 <150 = 149 <150 = lab value 
or 149 
<120 = 119 <120 = lab 
value or 119 
Correlation 
(p-value) 
0.09451 
(0.6392) 
0.18170 
(0.3644) 
0.17248 
(0.3896) 
0.16717 
(0.4646) 
 
From the results of the correlation analysis it is no evidence of a correlation between 
the significant errors committed and the errors in test results. While no correlation 
existed between the significant errors committed and the errors in test results, one 
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cannot assume that errors in user operation of the kits might not ultimately result in 
poor test results. 
5.5 Subjective Comments from Users 
After using both the test kits the participants were asked whether they were 
willing to use the home cholesterol test kits again. This question was asked to get their 
opinion on cholesterol test kit for future use. Price was a major factor that effected 
their decision. Most of the participants were not willing to spend more that $20 to $40 
on these test kits. Ease of use and speed of results also effected their decision. Some 
of the participants felt that the home cholesterol test kits would be really helpful in 
keeping constant check on their cholesterol between the annual check-ups at the 
doctor’s clinic. They also felt that the using these test kits was easier than visiting a 
doctor. Few of the participants wanted to know the accuracy of the home test kits 
results when compared to the laboratory test results before making a decision. A few 
people felt that the Home Access® Instant Cholesterol Test required too much blood 
to give accurate results. Few of the participants, who were already seeing a doctor, 
were suffering from high LDL. They wanted a test kit that would give them the LDL 
value. It was a new experience for all the participants as none of them had ever heard 
of home cholesterol test kit until they participated in the study. 
After getting the laboratory cholesterol results from Pennington Medical 
Center, the laboratory test results were given to all the participants. They were asked 
their future healthcare plan based on the laboratory results to see if there was a change 
in the future healthcare plan when their cholesterol level increased or decreased as 
compared to the home test kit results. A few of the participants had far higher 
cholesterol as compared to the home test kit results. All the participants who had a 
cholesterol level higher than 220 mg/dL chose to change their lifestyle. The 
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laboratory test results consisted of total cholesterol, HDL, LDL and triglycerides 
value. Some of the participants were suffering from high LDL and chose to see a 
doctor at the earliest convenience.  
After getting the laboratory results the participants were given the error for 
each of the test kits they used. They were again asked their opinion on using the home 
cholesterol test kits for future use. This question was asked to see if the difference 
between the laboratory results and the test results affected their opinion on using the 
home test kits in future. Most of the participants whose test kit results differed greatly 
when compared to the laboratory results, changed their opinion on using the test kits. 
Most of them felt that the tests were not accurate and they were not willing to spend 
money on test kits when they were not confident of getting correct results. 
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6. DISCUSSION 
From the results of the ANOVA for hypothesis 1, it was observed that there is 
no relation between the type of test kit and the error in the test results when the test 
results of each test kit were compared to the laboratory results. A correlation analysis 
was performed to determine the correlation between the test results for each test kit 
and the laboratory results. The results of the correlation differ from the results of the 
ANOVA. The results of the correlation analysis showed that the Accuchek® Instant 
plus® test results and the laboratory test results were highly correlated but the Home 
Access® Instant Cholesterol Test results were marginally correlated to the laboratory 
test results. A paired t-test was performed to check whether the number of significant 
errors committed while using each of the test kits affected the test results. The results 
of the t-test show highly significant evidence that the participants committed more 
significant errors while using Home Access® Instant Cholesterol Test than while 
using Accuchek® Instant plus®. The results of the correlation analysis can be 
explained by the results of the paired t-test. As the number of significant errors 
committed while using Home Access® Instant Cholesterol Test is higher than those 
committed while using Accuchek® Instant plus®, the results of Accuchek® Instant 
plus® are highly correlated to the laboratory results when compared to the Home 
Access® Instant Cholesterol Test results. Irrespective of the number of significant 
errors committed, the contribution of the errors might have been equal. The results of 
ANOVA support the above statement. Hence, we have significant evidence to accept 
hypothesis 1. 
A correlation analysis was performed to check whether, the number of 
significant errors committed while using each of the test kits affected the error 
between the test results and the laboratory results. The results of the correlation 
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analysis show that there was no correlation between the number of errors committed 
and the errors in the test results. Hence, we can state that though the participants 
committed more significant errors while using Home Access® Instant Cholesterol 
Test than Accuchek® Instant plus®, it did not affect the end result. While no 
correlation existed between the significant errors committed and the errors in test 
results, one cannot assume that errors in user operation of the kits might not 
ultimately result in poor test results. This is the same conclusion drawn from the 
results of the ANOVA.  
Some of the participants in the study were already seeing a doctor so the test 
results did not effect their future healthcare decision. Among the 30 participants, 22 
(11 men and 11 women) of them were not seeing a doctor.  These 22 participants 
were considered for the statistical analysis of hypothesis 2. From the predictor P 
values for male and female subjects (table 5.6 and figure 5.1), it was observed that 
irrespective of the gender of the participant, as the cholesterol level of the participant 
increased from 119 mg/dL to 254mg/dL the participants said that they were more 
likely to change their lifestyle rather than visit a doctor. As the cholesterol level 
increased, the predicted probability to choose not to change ones lifestyle decreased 
and the predicted probability to change ones lifestyle increased. Men said that they 
would change their lifestyle at a lower cholesterol level than women. For women, 
there was a sharp increase in the predicted probability to change ones lifestyle 
between 186.5 mg/dL and 220 mg/dL. According to the National Cholesterol 
Education Program (NCEP) expert panel, cholesterol levels between 200 mg/dL and 
238 mg/dL are considered to be borderline high (refer table 2.1 in the literature review 
section). It can be stated that women tend to worry when their cholesterol levels are 
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nearing the borderline high category. Hence, we have significant evidence to reject 
hypothesis 2. 
It was strange to note that as the cholesterol level increased, there was a slight 
decrease in the predicted probability to see a doctor. The change in the predicted 
probability to visit a doctor was negligible regardless of the increase in cholesterol 
level.  This is a matter of concern. People having cholesterol higher than 238 mg/dL 
are at a high risk of heart attack and their cholesterol should be brought down as soon 
as possible. But, if they neglect going to the doctor and try to reduce their cholesterol 
by changing their lifestyle, the remedy may not be very effective. The purpose of 
home cholesterol test kits is completely reversed. The home cholesterol test kits were 
manufactured to help people have better knowledge of their cholesterol level and help 
them go to the doctor at the right time before it is too late. From the results of the 
statistical analysis, it can be seen that this purpose is not being served. 
In hypothesis 3 we are comparing the usability of the two test kits used. 
Though the end result of the two test kits was the same, the procedure followed to get 
the result was completely different. Figure 6.1 shows the instruction card that was 
used by the participants to perform the test. The Accuchek® Instant plus®, digital test 
kit, was found to have major flaws in its instruction card.  
Most of the participants were not able to insert the test strip in their first 
attempt. The instruction card had no picture showing the correct side of the test strip 
that should be inserted (Figure 6.1, refer Appendix J for larger view). The error card 
also gave very little information as to how to rectify the error committed. The 
procedure to remove the test strip was also not specified in the error card. After 
inserting the test strip the next instruction stated “open the protective cover”. The 
instruction card did not give a picture of the protective cover. Even on the test meter, 
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there was no sign to direct the users to the protective cover. All the participants had to 
search for the protective cover before they managed to open it. Two of the 
participants got frustrated searching for the protective cover and quit the test. 
 
 
 
 
 
 
 
 
Figure 6.1: Instruction card for Accuchek® Instant plus® 
 After performing a finger stick the users are asked to apply a hanging drop of 
blood at the center of the test strip. After this instruction, the instruction stated that “if 
testing for cholesterol, wipe off the first drop of blood. Apply second drop of blood to 
test pad” (refer to the box in Figure 6.1).  Most of the participants read this instruction 
after applying blood on the test pad. The amount of blood to be applied on the test pad 
is shown in a picture at the end of the test. By the time the participants looked at the 
picture they had already finished applying blood and closed the protective cover. The 
participants were also given the Accuchek® Instant plus® user manual for reference 
if they were unclear with any of the instructions in the instructions card “quick 
reference guide”. Around 28 of the 30 participants were not interested in reading the 
user manual to perform the test. They stated that they did not have time to read 
through a manual to perform the test although they were not given any instructions 
that limited their time to complete the test. Most of the errors committed while using 
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the Accuchek® Instant plus® meter were commission errors (i.e., incorrect insertion 
of test strip and improper blood application on the test pad). The Accuchek® Instant 
plus® test kit gets switched off in 3 minutes after it is switched on. This information 
is not given in the user manual or in the quick reference guide. Some of the 
participants switched on the meter first and then continued reading the instructions. 
By the time they inserted the test strip, opened the protective cover and applied blood 
on the test pad, the meter would get switched off. The participants had to repeat the 
test again. They were quite frustrated at that time and were not able to do the test as 
well as they had done the first time. The different errors committed by participants 
while using Accuchek® Instant plus® were improper insertion of test strip, not 
wiping off the first drop of blood not closing the protective cover within 5 second of 
applying blood to the test pad and insufficient amount of blood on the test strip. 
Improper insertion of test strip would not have affected the test result but all the other 
errors are significant errors which would have affected the test results. 
 All the participants felt that the instructions for the Home Access® Instant 
Cholesterol Test kit were better organized and helpful as compared to the Accuchek® 
Instant plus® test kit. The pictorial presentation of the instructions helped in better 
user performance. A stop sign was given and the instruction “use the gauze pad to 
wipe off the first sign of blood from your finger, Failure to do so may affect your 
result” was stated in red as show in Figure 6.2. 
 
  
 
 
Figure 6.2: The ‘STOP’ sign as in the instructions for Home Access® Instant 
Cholesterol Test 
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Though the instruction was specified clearly, some of the participants failed to 
follow the instruction. The major problem with this test kit was the amount of blood 
required to perform the test. The participants had to fill a well till the black circle was 
completely covered. A large amount of blood was to be applied to complete this step. 
Most of the participants were unable to squeeze out enough blood to complete the 
step. The participants had to wait for 2 to 4 minutes before performing the next step. 
Some of the participants did not wait the required amount of time and proceeded to 
the next step. After the tab is pulled completely the test meter is to be tapped 2 to 3 
times to activate the test. If the test meter is not tapped properly, the result is affected. 
The test result is read after the “end” indicator turns green. The very tip of the purple 
color bar is to be read, even if it is fuzzy and faint. Most of the participants were not 
sure if they were reading their result correctly. The very tip of the purple fuzzy bar 
was difficult to determine. There might have been an error in reading the purple bar 
which might have contributed to the error in the test result. The different errors 
committed while using the Home Access® Instant Cholesterol Test kit are not wiping 
off the first drop of blood, insufficient amount of blood in the well, pulling the tab 
before 2 minutes or after 4 minutes and not tapping the meter properly. All the above 
mentioned errors can be classified as significant errors which may affect the end 
result. 
When the total number of errors committed while using each of the test kits 
was compared, it was found that the participants committed significantly more errors 
while using the Accuchek® Instant plus® meter than the Home Access® Instant 
Cholesterol Test kit. Participants committed significantly more commission errors 
while using Accuchek® Instant plus® than while using the Home Access® Instant 
Cholesterol Test kit but they committed significantly more timing errors while using 
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Home Access® Instant Cholesterol Test than while using the Accuchek® Instant 
plus® meter. When the number of omission errors committed while using each of the 
two test kits were compared, they were not significantly different from each other. 
Results of the paired t-test for significant errors showed that significantly more errors 
were committed while using Home Access® Instant Cholesterol Test than while using 
the Accuchek® Instant plus® meter. There is evidence rejecting hypothesis 3.The 
results of the usability questionnaire, comparison questionnaire and the post 
questionnaire show that the participants rated the test kits equally on the basis of 
usability.   
The attitude of the participants on using the cholesterol tests kits to keep a 
constant check on their cholesterol, changed after they received their laboratory test 
results. The accuracy of the test kit was a major concern. The cost of the testing kit 
also played a major role in this change of decision. Most of the participants were 
unwilling to spend even $20 on test kits if they did not have the assurance of its 
accuracy. It can be concluded the decision to use the test kits in future depends on the 
cost of the test kit, the accuracy of the test results and the ease with which it can be 
used. 
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7. CONCLUSIONS AND RECOMMENDATIONS 
7.1 Conclusions 
Usability analysis was conducted on home cholesterol testing kits using two 
different types of meters. It was found that the procedural instructions needed to be in 
a proper sequential manner for the successful completion of the test.  
  Statistical analysis reveled that the error in the test result when compared to 
the laboratory result did not depend on the type of the test kit. There is room for error 
in both the testing kits and from the results of the video analysis it can be concluded 
that the participants did commit number of significant errors irrespective of the testing 
kit used. From the nominal logistic analysis it was concluded that men and women 
differed on health care decision point for transition to a changing lifestyle. As the 
cholesterol levels increased it was noticed that the participants said they would change 
their life style rather than visit the doctor. It was strange to note that regardless of the 
cholesterol level the participants never preferred to visit a doctor. This was observed 
for both men and women alike.  
From the video analysis it can be concluded that the user performance 
depended on the type of test kit being used. Significantly more errors were committed 
while using Accuchek® Instant plus® than Home Access® Instant Cholesterol Test. 
From the statistical analysis of the questionnaire study it was found that both the kits 
were rated equally when they were first used. There was an ordering effect on the 
usability score. From the post results study it can be concluded the decision to use the 
test kits in future depends on the cost of the test kit, the accuracy of the test results 
and the ease with which it can be used. 
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7.2 Recommendations 
Better design of the testing kit by providing sequential procedural instructions 
could improve the accuracy of these testing kits. It is also recommended that these 
instructions provided in a stepwise pictorial manner could yield better results. The 
variation in results while performing statistical analysis can be attributed to the 
variation in sample size for each analysis. A larger sample size is recommended for 
more stabilized results. A matter of concern is the decision of the participants to 
change their lifestyle rather than visiting a doctor regardless of their cholesterol level. 
This aspect needs further investigation. The participants in this study represented 
employees from the Louisiana State University. When using larger sample sizes, it is 
recommended  that participants should be chosen from a larger population.  
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APPENDIX A 
DEMOGRAPHIC QUESTIONNAIRE 
Subject Number:  ___________ 
  
1. Which category best describes your age? 
a) below 30  
b) 30-40 
c) 40-50 
d) 50-60 
e) 60-70 
f) 70-80 
g) 80 and above 
 
2. What is your gender? 
a) Male 
b) Female 
 
3. What category best describes your income? 
a) $0-$14,999 
b) $15,000-$29,999 
c) $30,000-$44,999 
d) $45,000-$59,999 
e) $60,000-$74,999 
f) $75,000-$89,999 
g) $90,000 and above 
 
4. Which category best describes your educational status? 
a) Below middle school  
b) Middle school/ Jr High 
c) High school 
d) Some college 
e) 2-year degree 
f) 4-year degree 
g) Masters degree and higher 
 
5. Which category best describes your ethnicity? 
a) African American 
b) Caucasian 
c) Asian 
d) Hispanic 
e) Pacific Islander 
f) Native American 
g) European 
 
6. What kind of medical insurance do you have? 
a) Medicare 
b) Private insurance 
 
7. Have you ever had your cholesterol numbers checked? 
 62
a) Yes 
b) No  
 
8. How often do you get your cholesterol checked? 
a) Once a week 
b) Once in two weeks 
c) Once in a month 
d) Never checked  
 
9. Have you ever heard of home cholesterol test kits? 
a) Yes 
b) No   
 
  9. Have you ever used a home cholesterol test kit? 
a) Yes 
b) No 
 
10. I f the answer to the above question is ‘yes’, what is the name of the product 
and     how much does it cost? 
 
  Name of product: ________________________ 
 Cost of the product: ______________________ 
 
11. How much money are you willing to spend on the home health testing kits? 
 
a) none 
b) less than $20 
c) $20 to 40 
d) $ 40 to $60 
e) $60 to $150 
f) $150 to $250  
g) more than $250 
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APPENDIX B 
USABILITY QUESTIONNAIRE – Accuchek® Instant plus® 
(DIGITAL DISPLAY) 
Subject Number: ___________ 
 
Please circle the response that best represents your opinion to the following questions. 
 
1. Is it easy to learn the procedure of the test? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
                                                                                                                  
                                                                
2. Is it easy to remember how to perform the test? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
 
 
3. Is the amount of effort required to learn the test procedure acceptable? 
        1                   2                       3  4          5 
Very Acceptable     Acceptable         Borderline     Unacceptable    Very Unacceptable 
 
 
4. Is the amount of time taken to learn the test acceptable? 
        1                   2                       3  4          5 
Very Acceptable   Acceptable         Borderline      Unacceptable     Very Unacceptable 
 
 
5. How helpful are the instructions in performing the test? 
        1                   2                       3  4          5 
Very Helpful              Helpful              Borderline     Unhelpful             Very Unhelpful 
 
 
6. Are the instructions presented in a proper step-by-step manner? 
   1               2                  3          4          5 
Strongly Agree          Agree               Borderline          Disagree        Strongly Disagree      
 
                                                                                                                                                               
7. Are the instructions legible and clear? 
   1               2                  3          4          5 
Strongly Agree          Agree               Borderline          Disagree        Strongly Disagree      
 
 
8. How easy is it to insert the test strip? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
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9. How easy is it to draw blood using the lancet? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
 
 
10. Are you satisfied with the size of the test strip you used? 
        1                    2                       3     4          5 
Very Satisfied       Satisfied            Borderline      Unsatisfied       Very Unsatisfied  
 
 
11. How do you rate the design of the kit? 
        1                    2                       3     4          5 
Excellent                Good               Borderline                   Bad                 Very Bad 
 
 
12. How do you rate your interaction with the kit? 
        1                    2                       3     4          5 
Excellent                Good               Borderline                   Bad                 Very Bad 
 
 
13. How satisfied are you with your performance of completing the test? 
        1                    2                       3     4          5 
Very Satisfied       Satisfied            Borderline      Unsatisfied       Very Unsatisfied  
 
 
14. Are you satisfied with the time taken to perform the test? 
        1                    2                       3     4          5 
Very Satisfied       Satisfied            Borderline      Unsatisfied       Very Unsatisfied  
 
 
15. Are you satisfied with the way you were presented the test results? 
        1                    2                       3     4          5 
Very Satisfied       Satisfied            Borderline      Unsatisfied       Very Unsatisfied  
 
 
16. Do you believe that the test results are a true representation of your cholesterol 
numbers? 
         1                   2                      3              4          5 
Strongly Agree        Agree               Borderline       Disagree     Strongly Disagree      
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APPENDIX C 
USABILITY QUESTIONNAIRE – HOME ACCESS® INSTANT 
CHOLESTEROL TEST (METER BASED TEST) 
Subject Number: _________ 
 
Please circle the response that best represents your opinion to the following questions. 
 
1. Is it easy to learn the procedure of the test? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
                                                                                                                  
                                                                
2. Is it easy to remember how to perform the test? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
 
 
3. Is the amount of effort required to learn the test procedure acceptable? 
        1                   2                       3  4          5 
Very Acceptable     Acceptable         Borderline   Unacceptable      Very Unacceptable 
 
 
4. Is the amount of time taken to learn the test acceptable? 
        1                   2                       3  4          5 
Very Acceptable   Acceptable         Borderline     Unacceptable      Very Unacceptable 
 
 
5. How helpful are the instructions in performing the test? 
        1                   2                       3  4          5 
Very Helpful              Helpful              Borderline     Unhelpful             Very Unhelpful 
 
 
6. Are the instructions presented in a proper step-by-step manner? 
   1               2                  3          4          5 
Strongly Agree          Agree               Borderline          Disagree        Strongly Disagree      
 
                                                                                                                                                               
7. Are the instructions legible and clear? 
   1               2                  3          4          5 
Strongly Agree          Agree               Borderline          Disagree        Strongly Disagree      
 
 
8. How easy is it to draw blood using the lancet? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
 
9. Is it easy to place blood on the region given on the test kit to place the blood? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
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10. How do you rate the design of the kit? 
        1                    2                       3     4          5 
Excellent                Good               Borderline                   Bad                 Very Bad 
 
 
11. How do you rate your interaction with the kit? 
        1                    2                       3     4          5 
Excellent                Good               Borderline                   Bad                 Very Bad 
 
 
12. How satisfied are you with your performance of completing the test? 
        1                    2                       3     4          5 
Very Satisfied       Satisfied            Borderline      Unsatisfied       Very Unsatisfied  
 
 
13. Are you satisfied with the time taken to perform the test? 
        1                    2                       3     4          5 
Very Satisfied       Satisfied            Borderline      Unsatisfied       Very Unsatisfied  
 
 
14. Are you satisfied with the way you were presented the test results? 
        1                    2                       3     4          5 
Very Satisfied       Satisfied            Borderline      Unsatisfied       Very Unsatisfied  
 
 
15. Is it easy to interpret the test results? 
        1                    2                       3     4          5 
Very   Easy             Easy                 Borderline             Hard                Very Hard   
 
16. Do you believe that the test results are a true representation of your cholesterol 
numbers? 
         1                   2                      3              4          5 
Strongly Agree          Agree               Borderline      Disagree      Strongly Disagree      
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APPENDIX D 
COMPARISON QUESTIONNAIRE 
Subject Number: ___________ 
 
Please circle the response that best represents your opinion to the following questions. 
      1                           2                              3                                4                               5  
Strongly                  Agree                     Borderline                Disagree              Strongly  
Agree                                                                                                                  Disagree 
 
1. It is easy to learn the procedure of the test. 
 
Accuchek® Instant plus®                          Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
                                                                
2. It is easy to remember how to perform the test. 
 
Accuchek® Instant plus®                          Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
3. The amount of effort required to learn the test procedure is acceptable. 
 
Accuchek® Instant plus®                          Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
4. The amount of time taken to learn the test is acceptable. 
 
Accuchek® Instant plus®                          Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
5. The instructions given with the test kit are helpful in performing the test. 
 
Accuchek® Instant plus®                          Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
6. The instructions are presented in a proper step-by-step manner. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
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7. The instructions are legible and clear. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
8. It is easy to draw blood using the lancet given in the kit. 
 
Accuchek® Instant plus®                        Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
9. It is easy to place blood on the test (strip) or the region given on the test kit to 
place the blood. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
10. The design of the kit is apt for this kind of test. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
11. It is easy to interact with the kit. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
12. How satisfied are you with your performance of completing the test? 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
13. The time taken to perform the test is sufficient. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
14. The presentation of the test results is easy to understand. 
 
Accuchek® Instant plus®                          Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
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15. It easy to interpret the test results. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
16.  The test results are a true representation of your cholesterol numbers. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
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APPENDIX E 
POST -TEST QUESTIONNAIRE 
Subject Number: _________ 
 
PART A 
 
1. Do you think the results of the home cholesterol test kit are accurate and 
represent your true cholesterol numbers? 
 
      1                           2                              3                           4                       5  
Highly                 Accurate                 borderline          Inaccurate      Highly Accurate                                  
Inaccurate 
 
2. According to your test results, what is your cholesterol level?  
 
Total Cholesterol  
 
(Accuchek® Instant plus®)                      (Home Access® Instant Cholesterol test) 
 
Value: _______________                              Value: __________________                                               
 
a)Desirable (less than 200 mg/dL)                a)Desirable (less than 200 mg/dL) 
b)Borderline high (200-239 mg/dL)              b)Borderline high (200-239 mg/dL) 
c) High (240 mg/dL or above)                       c) High (240 mg/dL or above) 
 
 
3. Are you willing to use the home cholesterol test kit again, to test your cholesterol 
level? 
 
   1               2                       3     4          5 
Strongly            Agree                   Borderline                 Disagree           Strongly 
Agree                                                                                                        Disagree                                
 
 
4. Why would/ wouldn’t you use the home cholesterol test kit again? 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
________________________ 
 
5. What is your future health care plan based on the cholesterol numbers for the 
home cholesterol test? 
 
a) Visit a doctor 
b) Change in lifestyle 
c) No change in lifestyle or visit to a doctor 
d) Others 
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If others, state your future health care plan. 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
_______________ 
 
PART B – (comparison with Laboratory results) – Follow on study 
 
1. According to your laboratory results, what are your cholesterol levels? 
 
Total Cholesterol 
 
Value: _______________ 
 
a) Desirable (less than 200 mg/dL) 
b) Borderline high (200-239 mg/dL) 
c) High (240 mg/dL or above) 
 
 
2. How do your lab results differ from your home cholesterol test results? 
 
Total Cholesterol (Home Access® Instant Cholesterol Test) 
a) Exactly equal 
b) Different but in the same range 
 
Lab results are greater by ____________ mg/dL 
Lab results are less by ____________ mg/dL 
 
c) Entirely in a different range  
Lab results are greater by ____________ mg/dL 
Lab results are less by ____________ mg/dL 
 
Total Cholesterol (Accuchek® Instant plus®)
 
a) Exactly equal 
b) Different but in the same range 
 
Lab results are greater by ____________ mg/dL 
Lab results are less by ____________ mg/dL 
 
c) Entirely in a different range  
Lab results are greater by ____________ mg/dL 
Lab results are less by ____________ mg/dL 
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3.  How would you rate the home cholesterol test kits on the basis of the following? 
 
(Please circle the response that best represents your opinion) 
 
      1                           2                              3                 4                               5  
Strongly                  Agree                 Borderline       Disagree        Strongly Agree                                       
Disagree 
 
 
a) The results are accurate and show my correct cholesterol level 
 
Accuchek® Instant plus®                          Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
b) The test is reliable 
 
Accuchek® Instant plus®                          Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
c) The test results depend on the procedure followed to perform the test. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
d) The results depend on the design of the test kit. 
 
Accuchek® Instant plus®                         Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
e) The price of the kit is within my range 
 
Accuchek® Instant plus®                        Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
 
f) I would use the kit to keep a constant check on my cholesterol level 
 
Accuchek® Instant plus®                        Home Access® Instant Cholesterol Test 
 
       1       2      3       4       5                                               1       2      3       4       5 
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4.  Did you change your decision on your future health care plan after comparing your 
laboratory results with the home cholesterol test results? 
 
a) Yes 
b)  No 
 
5. Reasons for changing /not changing your decision on your future medical plan? 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
____________ 
 
6. Are you willing to use the home cholesterol test kit again, to test your cholesterol 
level? 
   1               2                       3     4          5 
Strongly            Agree                    Borderline                Disagree            Strongly 
Agree                                                                                                       Disagree                                
 
7. Has your decision on using the home cholesterol test kit for testing your 
cholesterol levels in future, changed? 
a) Yes 
b) No 
 
8. Reasons for changing/ not changing your decision on using the home cholesterol 
test kit for testing your cholesterol levels in future. 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
____________ 
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APPENDIX F 
VIDEO ANALYSIS WORKSHEET 
 
 
Subject Run Procedure No. Procedure HH M SS TT Begin HH M SS TT end dec Response Error Gender
1 read instructions
ACC turn meter on
insert test strip
open protective cover
wipe finger wih alcohol swaps
stick your finger
wipe off first drop of blood
apply blood on the yellow pad of the test strip
the yellow test pad must be filled with blood 
close protective cover within 5 sec
countdown begins
read results
2 read instructions
IC place the contents on the table
warm your hands
wipe hands using alcohol swaps
place lancet on the table
stick you finger by pushing your finger firmly
wipe off first drop of blood
apply hanging drop of blood to the well till black 
wait for 2 to 4 minutes
pull the plastic tab till completely arrow appears
tap the device on the table 2-3 times
Ok' indicator turns purple - test starts
END' turns green in 10-12 minutes
read results
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APPENDIX G 
RESULTS OF KRUSKAL WALLIS TEST  
 
Hypothesis 1 
 
1. Case 1: <150=149 and <120=119 
 
Chi-Square 0.4215 
DF 1 
Pr > Chi-Square  0.5162 
 
2.         Case 2: <150 and <120 are equal to lab value or 149/119 whichever is closer 
 
Chi-Square 1.7330 
DF 1 
Pr > Chi-Square  0.1880 
 
Hypothesis 3 
 
1. Usability Questionnaire analysis 
 
Chi-Square 0.0004 
DF 1 
Pr > Chi-Square 0.9834 
 
2. Comparison Questionnaire analysis 
 
Chi-Square 0.5653 
DF 1 
Pr > Chi-Square 0.4521 
 
3. Post Questionnaire analysis 
 
Chi-Square 2.1975 
DF 1 
Pr > Chi-Square 0.1382 
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APPENDIX H 
EXCEL TABLES USED FOR STATISTICAL ANALYSIS 
 
Hypothesis 1 
 
1. Tables for ANOVA 
 
a. Approximating all <150 to 149 and <120 to 119 
 
Meter  Error  Meter Error 
Accuchek 6  instant 13
Accuchek 57  instant 39
Accuchek 6  instant 4
Accuchek 43  instant 13
Accuchek 7  instant 21
Accuchek 3  instant 39
Accuchek 66  instant 34
Accuchek 49  instant 17
Accuchek 9  instant 8
Accuchek 38  instant 39
Accuchek 13  instant 5
Accuchek 47  instant 181
Accuchek 35  instant 129
Accuchek 40  instant 10
Accuchek 0  instant 30
Accuchek 2  instant 45
Accuchek 1  instant 2
Accuchek 4  instant 13
Accuchek 23  instant 128
Accuchek 4  instant 11
Accuchek 21  instant 55
Accuchek 5  instant 18
Accuchek 47  instant 20
Accuchek 23  instant 23
Accuchek 78  instant 2
Accuchek 4  instant 18
Accuchek 48  instant 44
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b. Approximating <150 and <120 to either the lab values or to 149/119 whichever is 
closer 
 
Meter  Error  Meter Error 
Accuchek 6  instant 13
Accuchek 57  instant 39
Accuchek 6  instant 4
Accuchek 0  instant 0
Accuchek 7  instant 21
Accuchek 3  instant 39
Accuchek 66  instant 34
Accuchek 49  instant 17
Accuchek 9  instant 8
Accuchek 38  instant 39
Accuchek 13  instant 5
Accuchek 47  instant 181
Accuchek 35  instant 129
Accuchek 0  instant 0
Accuchek 0  instant 30
Accuchek 2  instant 45
Accuchek 1  instant 2
Accuchek 4  instant 13
Accuchek 23  instant 128
Accuchek 4  instant 11
Accuchek 21  instant 55
Accuchek 5  instant 18
Accuchek 0  instant 20
Accuchek 23  instant 23
Accuchek 78  instant 2
Accuchek 4  instant 18
Accuchek 48  instant 44
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2. Tables used for correlation 
 
a. Correlation between Laboratory results and test results by test kit type and gender 
 
(i) Approximating all <150 to 149 and <120 to 119 
 
 
Gender Meter 
Lab 
results 
Test 
results  Gender Meter 
Lab 
results 
Test 
results 
female Accuchek 209 215  male Accuchek 196 187
female Accuchek 220 163  male Accuchek 190 152
female Accuchek 148 154  male Accuchek 182 169
female Accuchek 106 149  male Accuchek 301 254
female Accuchek 241 248  male Accuchek 248 213
female Accuchek 216 213  male Accuchek 109 149
female Accuchek 215 149  male Accuchek 149 149
female Accuchek 198 149  male Accuchek 171 169
female Accuchek 168 167  male Accuchek 102 149
female Accuchek 202 198  male Accuchek 172 149
female Accuchek 247 270  male Accuchek 238 160
female Accuchek 185 189  male Accuchek 153 149
female Accuchek 251 230  male Accuchek 209 161
female Accuchek 162 157  male instant 196 204
female Instant 209 196  male instant 190 151
female Instant 220 181  male instant 182 177
female Instant 148 144  male instant 301 120
female Instant 106 119  male instant 248 119
female Instant 241 220  male instant 109 119
female Instant 216 177  male instant 149 119
female Instant 215 181  male instant 171 126
female Instant 198 181  male instant 102 122
female Instant 168 166  male instant 174 151
female Instant 202 189  male instant 222 220
female Instant 247 119  male instant 238 220
female Instant 185 196  male instant 209 165
female Instant 251 196      
female Instant 162 144      
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(ii) Approximating <150 and <120 to either the lab values or to 149/119 whichever is 
closer 
 
Gender Meter 
Lab 
results 
Test 
results  Gender Meter 
Lab 
results 
Test 
results
female Accuchek 209 215  male Accuchek 196 187
female Accuchek 220 163  male Accuchek 190 152
female Accuchek 148 154  male Accuchek 182 169
female Accuchek 106 106  male Accuchek 301 254
female Accuchek 241 248  male Accuchek 248 213
female Accuchek 216 213  male Accuchek 109 109
female Accuchek 215 149  male Accuchek 149 149
female Accuchek 198 149  male Accuchek 171 169
female Accuchek 168 167  male Accuchek 102 102
female Accuchek 202 198  male Accuchek 172 149
female Accuchek 247 270  male Accuchek 238 160
female Accuchek 185 189  male Accuchek 153 149
female Accuchek 251 230  male Accuchek 209 161
female Accuchek 162 157  male instant 196 204
female Instant 209 196  male instant 190 151
female Instant 220 181  male instant 182 177
female Instant 148 144  male instant 301 120
female Instant 106 106  male instant 248 119
female Instant 241 220  male instant 109 109
female Instant 216 177  male instant 149 119
female Instant 215 181  male instant 171 126
female Instant 198 181  male instant 102 122
female Instant 168 166  male instant 174 151
female Instant 202 189  male instant 222 220
female Instant 247 119  male instant 238 220
female Instant 185 196  male instant 209 165
female Instant 251 196      
female Instant 162 144      
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b. Correlation between the two test kits results (Accuchek® Instant plus® and Home 
Access® Instant Cholesterol Test) 
 
(i)  Approximating all <150 to 149 and <120 to 119 
(ii) Approximating <150 and <120 to either the lab values or to 149/119 whichever is 
closer 
 
Table (i)      Table (ii) 
 
Gender 
Accuchek® 
Instant 
plus® 
Home 
Access® 
Instant 
Cholesterol 
Test  Gender
Accuchek® 
Instant 
plus® 
Home 
Access® 
Instant 
Cholesterol 
Test 
female 215 196  female 215 196 
female 163 181  female 163 181 
female 154 144  female 154 144 
female 149 119  female 106 106 
female 248 220  female 248 220 
female 213 177  female 213 177 
female 149 181  female 149 181 
female 149 181  female 149 181 
female 167 166  female 167 166 
female 270 119  female 270 119 
female 189 196  female 189 196 
female 230 196  female 230 196 
female 157 144  female 157 144 
male 187 204  male 187 204 
male 152 151  male 152 151 
male 169 177  male 169 177 
male 254 120  male 254 120 
male 213 119  male 213 119 
male 149 119  male 109 109 
male 149 119  male 149 119 
male 169 126  male 169 126 
male 149 122  male 102 122 
male 160 220  male 160 220 
male 161 165  male 161 165 
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Hypothesis 2 
 
Table for Nominal logistic regression 
 
gender  result Decision decision 
female 119 3 No change in lifestyle/visit a doctor 
male 122 3 No change in lifestyle/visit a doctor 
female 144 3 No change in lifestyle/visit a doctor 
female 149 3 No change in lifestyle/visit a doctor 
female 149 3 No change in lifestyle/visit a doctor 
male 149 1 Change in  lifestyle 
male 151 2 Change in  lifestyle 
male 152 3 Change in  lifestyle 
female 163 1 Change in  lifestyle 
male 165 1 visit a doctor 
female 166 3 No change in lifestyle/visit a doctor 
male 169 2 visit a doctor 
male 187 3 No change in lifestyle/visit a doctor 
female 189 3 No change in lifestyle/visit a doctor 
female 196 1 visit a doctor 
female 196 3 No change in lifestyle/visit a doctor 
female 213 2 No change in lifestyle/visit a doctor 
male 213 2 visit a doctor 
female 215 2 visit a doctor 
male 220 2 Change in  lifestyle 
male 220 2 Change in  lifestyle 
male 254 2 Change in  lifestyle 
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Hypothesis 3 
 
1. Usabilility Questionnaire table 
 
Meter  Score  
Accuchek 24 
Accuchek 30 
Accuchek 43 
Accuchek 34 
Accuchek 41 
Accuchek 32 
Accuchek 26 
Accuchek 23 
Accuchek 31 
Accuchek 27 
Accuchek 34 
Accuchek 28 
Accuchek 33 
Accuchek 26 
Accuchek 37 
Accuchek 26 
Instant  32 
Instant  30 
Instant  29 
Instant  24 
Instant  42 
Instant  30 
Instant  34 
Instant  17 
Instant  21 
Instant  34 
Instant  44 
Instant  31 
Instant  77 
Instant  19 
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2. Comparison questionnaire table 
 
Meter  Score  
Accuchek 23 
Accuchek 32 
Accuchek 32 
Accuchek 29 
Accuchek 32 
Accuchek 32 
Accuchek 22 
Accuchek 23 
Accuchek 16 
Accuchek 34 
Accuchek 33 
Accuchek 22 
Accuchek 32 
Accuchek 25 
Accuchek 36 
Accuchek 35 
Instant  33 
Instant  33 
Instant  24 
Instant  41 
Instant  45 
Instant  27 
Instant  31 
Instant  25 
Instant  20 
Instant  27 
Instant  42 
Instant  32 
Instant  80 
Instant  17 
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3. Post Questionnaire table 
 
Meter  Score  Meter Score 
Accuchek 15  Instant  9 
Accuchek 23  Instant  9 
Accuchek 9  Instant  16 
Accuchek 6  Instant  16 
Accuchek 14  Instant  22 
Accuchek 10  Instant  13 
Accuchek 17  Instant  18 
Accuchek 18  Instant  23 
Accuchek 6  Instant  12 
Accuchek 11  Instant  8 
Accuchek 10  Instant  12 
Accuchek 12  Instant  14 
Accuchek 13  Instant  16 
Accuchek 9  Instant  12 
Accuchek 6  Instant  10 
Accuchek 11  Instant  9 
Accuchek 6  Instant  5 
Accuchek 6  Instant  11 
Accuchek 11  Instant  10 
Accuchek 9  Instant  21 
Accuchek 16  Instant  19 
Accuchek 6  Instant  7 
Accuchek 12  Instant  12 
Accuchek 9  Instant  7 
Accuchek 22  Instant  21 
Accuchek 12  Instant  14 
Accuchek 13  Instant  21 
Accuchek 11  Instant  16 
Accuchek 19  Instant  14 
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4. Video analysis tables 
 
a. Table for paired T-test for total errors and different types of errors 
 
Where, 
      C = Commission 
      O = Omission 
        S = Sequence 
       T = Timing 
 
1 represents Accuchek® Instant plus® 
2 represents Home Access® Instant Cholesterol Test 
 
C1 O1 T1  S1 Total C2 O2 T2 S2 Total 
0 0 0 0 0 0 0 0 0 0 
5 0 0 0 5 1 0 1 0 2 
2 0 1 1 4 0 1 2 0 3 
4 0 0 0 4 1 0 1 0 2 
5 0 0 0 5 2 0 1 0 3 
5 0 0 0 5 1 1 0 0 2 
3 1 0 0 4 1 1 1 0 3 
4 1 0 0 5 0 0 0 0 0 
1 0 1 0 2 0 0 1 0 1 
2 1 0 0 3 1 1 1 0 3 
1 0 0 0 1 0 0 1 0 1 
1 0 0 0 1 0 0 1 0 1 
1 0 0 0 1 0 1 1 0 2 
1 0 0 0 1 0 1 1 0 2 
5 0 1 0 6 1 1 1 0 3 
9 0 0 2 11 2 0 0 0 2 
7 1 0 0 8 4 1 0 0 5 
4 0 0 0 4 5 0 1 0 6 
2 0 0 0 2 0 0 0 0 0 
3 0 0 0 3 1 0 1 0 2 
4 1 0 0 5 1 1 0 0 2 
2 1 1 0 4 0 1 0 0 1 
2 0 0 0 2 1 0 1 0 2 
3 2 1 0 6 1 2 1 0 4 
0 0 0 0 0 0 1 0 0 1 
0 0 1 0 1 0 0 0 0 0 
2 1 0 0 3 0 0 0 0 0 
6 0 0 0 6 0 1 1 0 2 
3 0 0 0 3 2 0 1 0 3 
0 1 0 0 1 0 1 0 0 1 
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b.Table for validation of video analysis 
 
Where, 
      C = Commission 
      O = Omission 
        S = Sequence 
       T = Timing 
 
1 represents first analysis  
2 represents second analysis 
 
 
C2 O2 T2 S2 Total C1 O1 T1 S1 Total 
0 0 0 0 0 0 0 0 0 0 
2 0 0 0 2 5 0 0 0 5 
0 0 0 0 0 0 0 0 0 0 
1 0 0 0 1 1 0 1 0 2 
3 0 0 0 3 3 0 0 0 3 
1 1 0 0 2 1 1 0 0 2 
0 0 0 0 0 0 0 0 0 0 
3 1 0 0 4 3 1 0 0 4 
0 0 1 0 1 0 0 1 0 1 
1 0 1 0 2 1 1 1 0 3 
1 0 0 0 1 1 0 0 0 1 
0 0 0 0 0 0 0 1 0 1 
0 1 0 0 1 0 1 0 0 1 
0 0 0 0 0 1 0 0 0 1 
2 0 0 0 2 3 0 0 0 3 
3 0 0 0 3 5 0 0 1 6 
2 0 0 0 2 2 0 0 0 2 
3 0 0 0 3 3 0 0 0 3 
2 0 0 0 2 2 0 0 0 2 
1 0 0 0 1 1 0 0 0 1 
3 0 0 0 3 4 1 0 0 5 
0 1 0 0 1 0 1 0 0 1 
2 0 0 0 2 2 0 0 0 2 
3 0 0 0 3 3 0 0 0 3 
0 1 0 0 1 0 1 0 0 1 
0 0 1 0 1 0 0 1 0 1 
1 0 0 0 1 1 0 0 0 1 
4 0 0 0 4 5 0 0 0 5 
2 0 0 0 2 2 0 0 0 2 
0 1 0 0 1 0 1 0 0 1 
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c.Table for paired T-test for significant errors 
 
Accuchek® 
Instant 
plus® 
Home Access® 
Instant 
Cholesterol Test 
0 0 
0 2 
2 3 
1 2 
1 3 
1 2 
1 3 
2 0 
1 1 
2 3 
0 1 
1 1 
0 2 
0 2 
2 3 
3 2 
2 5 
1 6 
0 0 
1 2 
2 2 
2 1 
0 2 
3 4 
0 1 
1 0 
1 0 
0 2 
1 3 
1 1 
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Post Hoc Analysis 
 
1. Correlation between significant errors and the difference between test results and 
laboratory results  
 
(a) Accuchek® Instant plus® 
 
(i). All ‘<150’ value are approximated to 149. 
(ii). All ‘<150’ values are approximated to 149 or the laboratory value, which ever is 
closer 
 
     Table (i)                                                                Table (ii) 
 
Error in 
results  
Error in 
performance   
Error in 
results  
Error in 
performance  
9 0  9 0 
38 0  38 0 
13 2  13 2 
47 1  47 1 
35 1  35 1 
40 1  0 1 
0 1  0 1 
2 2  2 2 
6 1  6 1 
57 2  57 2 
1 0  1 0 
47 1  0 1 
6 0  6 0 
43 0  0 0 
7 3  7 3 
23 1  23 1 
3 0  3 0 
66 1  66 1 
49 2  49 2 
4 2  4 2 
23 3  23 3 
4 0  4 0 
78 1  78 1 
21 1  21 1 
5 0  5 0 
4 1  4 1 
48 1  48 1 
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(b) Home Access® Instant Cholesterol Test 
 
(i). All ‘<120’ value are approximated to 119. 
(ii). All ‘<120’ values are approximated to 119 or the laboratory value, which ever is 
closer 
 
   Table (i)                                          Table (ii) 
 
Error in 
results  
Error in 
performance  
Error in 
results 
Error in 
performance  
8 0  8 0 
39 2  39 2 
5 3  5 3 
181 2  181 2 
129 3  129 3 
10 2  0 2 
30 3  30 3 
45 0  45 0 
13 1  13 1 
39 3  39 3 
2 1  2 1 
20 1  20 1 
4 2  4 2 
13 2  0 2 
23 3  23 3 
21 2  21 2 
2 5  2 5 
39 0  39 0 
34 2  34 2 
17 2  17 2 
13 2  13 2 
128 4  128 4 
11 1  11 1 
18 0  18 0 
55 0  55 0 
18 2  18 2 
44 1  44 1 
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APPENDIX I 
DISCRETE ACTION CLASSIFICATION – SWAIN & GUTTMANN 
(1983) 
 
Type of error Definition 
Commission Involve performing an act incorrectly  
Omission Involve the failure to do something 
Sequence (subclass of errors of commission) occurs 
when a person performs a task, or step in a 
task, out of sequence 
Timing (subclass of errors of commission) occurs 
when a person fails to perform an action 
within the allotted time, either performing too 
fast or too slowly. 
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APPENDIX J 
Accuchek® Instant plus® INSTRUCTION CARD 
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